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ABSTRACT 
 
Susan Cleland Helm-Murtagh 
 
ADDRESSING HEALTH DISPARITIES:   
IS THERE A ROLE FOR PRIVATE PAYERS IN REDUCING  
THE INCIDENCE OF TYPE 2 DIABETES AMONG U.S. HISPANICS? 
(Under the direction of Sandra B. Greene, DrPH) 
 
 
There is a role for private payers to play in reducing the incidence of type 2 diabetes 
among Hispanics in the United States.  However, given the barriers to reducing or 
eliminating racial and ethnic health disparities in general that health plans currently face, 
successfully filling that role is a long-term proposition – one that must be preceded by much 
foundational work and patience by all stakeholders in the health care system.   In the 
meantime, there is a more critical and immediate role that all private payers should play, if 
they have not begun to do so already – and that is to join the fight to reduce all racial and 
ethnic disparities in health and health care.  Broader industry action will raise the level of the 
quality of care delivered to racial and ethnic minorities in general; improve the overall health 
of those populations; create additional momentum for necessary federal policy changes; 
enhance industry knowledge and expertise in addressing health disparities; increase the 
evidence base for program outcomes; and reduce the time it will take to solve this serious 
problem. 
The successful resolution of the overall problem of racial and ethnic health 
disparities, whether measured by prevalence or incidence, and regardless of the target 
population or the target disease, will require the involvement of and action by all health care 
system stakeholders – payers, providers, members, communities, the government, 
agencies, and foundations.  Health plans are in a unique position to influence the majority of 
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these players, through advocacy, strategies, interventions, incentives, partnerships, policies, 
and programs.  This study presents a series of best and promising practices for health plans 
to take to begin to address racial and ethnic health disparities. 
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CHAPTER 1:  INTRODUCTION 
 
Study Overview and Specific Aims 
 A health disparity is a particular type of difference in health; it is a difference in which 
disadvantaged social groups -- such as the poor, racial/ethnic minorities, women, or other 
groups who have persistently experienced social disadvantage or discrimination -- 
systematically experience worse health or greater health risks than more advantaged social 
groups.1 
In the United States, health disparities in the incidence and prevalence of disease 
between racial and ethnic groups are striking.2  For example, heart disease is the leading 
cause of death for all racial and ethnic groups in the United States, but rates of death from 
cardiovascular disease are about 30 percent higher among African American adults than 
among white adults.  In addition, in women, overweight and obesity are higher among 
members of racial and ethnic minority populations than in non-Hispanic white women.  In 
men, Mexican-Americans have a higher prevalence of overweight and obesity than non-
Hispanic men, and approximately 300,000 deaths in the United States each year are 
associated with obesity and overweight. Finally, the prevalence of diabetes among 
American Indians and Alaska Natives is more than twice that of the total population, and the 
Pima Indians of Arizona have the highest known prevalence of diabetes in the world. The 
prevalence of Type 2 diabetes is 70 percent higher among African Americans and nearly 
100 percent higher among Hispanics than among whites.2-4 
The list goes on; the presence of racial and ethnic health disparities is well known 
and documented, as are the impacts to individuals and to society.  To illustrate this point, 
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the 2003 Institute of Medicine report, Unequal Treatment:  Confronting Racial and Ethnic 
Disparities in Health Care, reviewed more than a hundred studies published in the last 
decade that focused on the direct and indirect effects of race and ethnicity in the process, 
structure and outcomes of healthcare.5  In addition, a March 2008 Google search on the 
term netted 815,000 “hits.”   The facts are indisputable:  Whether measured by disease 
prevalence or incidence, life expectancy, or infant mortality, Americans of African, Hispanic, 
Native American, or Alaskan Native origin experience poorer health outcomes than do their 
fellow white citizens.     
From an individual standpoint, those who suffer from chronic disease often 
experience severe degradations in quality of life – ranging from dependence on 
medications, an inability to afford treatment, mobility limitations, and a shortened life 
expectancy – just to name a few.  From a societal standpoint, disparities represent a basic 
inequity:  Why should an American’s racial or ethnic heritage determine his or her health 
status?   If those factors are not convincing enough, consider this:  Racial and ethnic health 
disparities are not just a “minority problem;” they add significant costs to the health care 
system, which are borne by all participants – federal, state and local governments; 
taxpayers; employers; employees; and anyone paying health insurance premiums or 
seeking health care. 
Understanding and addressing the drivers of ethnic and racial health disparities, 
then, is critical for national health, economic and social justice reasons.  At a national level, 
the groups experiencing poorer health status are growing as a proportion of the total US 
population,6 so it is easy to argue that the future of this nation’s health is at stake.  From an 
economic standpoint, this erosion of health status will continue to increase health care costs 
in a system that is already too expensive for a growing number of Americans.7   And finally, 

 
 
 
 3 
each and every American should have the opportunity to achieve his or her optimal health 
status, regardless of race or ethnicity. 
In order to begin solving the problem of racial and ethnic health disparities, we must 
first understand what causes such differences in health outcomes.  The robust discussion of 
this issue has generated a broad range of theories (and a vigorous ensuing debate) about 
the sources and drivers of health disparities.  The evidence of racial and ethnic disparities in 
healthcare is remarkably consistent across a range of healthcare services and diseases – 
with few exceptions.  These disparities are associated with socioeconomic differences.  In a 
few cases, they diminish significantly or disappear completely when such factors are 
controlled.5 The majority of studies find, however, that disparities persist even after adjusting 
for socioeconomic differences and other healthcare access-related factors.8-10 Furthermore, 
biological differences between racial and ethnic groups as a source of the variations among 
them in areas such as disease incidence and prevalence, life expectancy, and infant 
mortality have generally been discarded in favor of three broad categories of drivers:  health 
system factors, patient-level factors and patient/provider interaction.11  
The Institute of Medicine’s groundbreaking study asserts that health disparities exist 
even when insurance coverage and ability to pay are not factors.  Furthermore, it states that 
racial and ethic differences in patient preferences, care-seeking behaviors, and attitudes 
toward care do not fully explain health disparities; instead, key drivers of disparities are 
present in the operation of healthcare systems and the clinical encounter. What does this 
mean?   Factors such as cultural and linguistic barriers, the geographic availability of 
healthcare institutions, provider bias (or prejudice) against minorities, greater clinical 
uncertainty that providers experience when interacting with minority patients, and beliefs or 
stereotypes held by the provider about the behavior or health of minorities are important 
drivers of healthcare disparities (see Figure 1).5  
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Figure 1.  Differences, Disparities and Discrimination:  Populations with Equal Access 
to Healthcare.12 
 
 
This theory suggests that potential solutions to racial and ethnic health disparities lie 
in the actual delivery of health care.  In other words, the ways in which individuals at risk for 
certain diseases or conditions are identified, evaluated, educated, treated, and monitored 
play key roles in whether they develop a disease or condition; they also impact how (and 
how well) that disease or condition is managed by the patient over time.   
Many private payers have begun to develop various methods to address the rising 
costs of some of the very same chronic conditions that are over-represented in minority 
populations.13 Such methods include provider “pay for performance” programs, care quality 
scorecards, disease management and population health management programs.  While 
these approaches show great promise in addressing the two key drivers of racial and health 
disparities proposed by the Institute of Medicine study committee -- the operation of 
healthcare systems and the clinical encounter -- the vast majority of these programs 
currently do not focus on racial or ethnic groups.  Members of these groups are usually 
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captured in the process of identifying affected or high-risk health plan members.  As a result, 
most current programs do not include, for example, the collection and storage of race or 
ethnicity demographic data, or the explicit provision of culturally and linguistically 
appropriate services (CLAS) – and the lack of CLAS is described by many sources describe 
as an important contributor to health disparities.14-16   
Furthermore, in spite of the broad awareness and discussion of the topic of health 
disparities, there have been few attempts to evaluate and summarize the available evidence 
about the effectiveness of interventions designed to improve health outcomes among 
racial/ethnic minorities and reduce health disparities.  Those that do evaluate effectiveness 
focus on managing the disease, as opposed to preventing it – in effect, controlling costs and 
managing quality of life instead of avoiding costs and maximizing quality of life.  In addition, 
none address the potentially powerful role that private payers can play in reducing health 
disparities.  This is surprising, given the ability of payers to influence the funding and 
delivery of health care and patient and provider actions through the multiple facets of the 
payer/provider and payer/patient relationship.   
This study will seek to fill those critical gaps by answering the following question:  
What specific measures can private (e.g., non-government) payers take to reduce health 
disparities in type 2 diabetes incidence among adult Hispanics in the United States?    Type 
2 diabetes was chosen because racial and ethnic minorities bear a disproportionate burden 
of the diabetes epidemic; minorities experience higher prevalence rates, worse diabetes 
control, and higher rates of complications.17    
Why Hispanics?  First, Hispanics are by far the fastest-growing racial/ethnic segment 
of the U.S. population, and they are falling further behind whites in quality of health care -- 
while other minority groups are closing the gapa.  The federal government, using data mostly 
                                               
a This is particularly true for the treatment of diabetes, mental illness and tuberculosis. 
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 6 
from 2002 and 2003, measured 40 types of disparities in the quality of health care between 
whites and minorities. Among blacks, 58 percent of those disparities were becoming smaller 
and 42 percent were becoming larger.  In contrast, among the disparities between whites 
and Hispanics, 41 percent were becoming smaller, while 59 percent were growing.18   With 
respect to diabetes in particular, Hispanics in the United States are twice as likely as white 
Americans to be diagnosed with the disease.19 
It is important to note that the Hispanic population in the United States is culturally 
heterogeneous and includes individuals of Mexican, Puerto Rican, Cuban, and Spanish 
descent – and of many other Latino countries.  While health outcomes do vary between 
these sub-populations, the overall health of the U.S Hispanic population as a group is poorer 
than that of U.S. whites, particularly when it comes to type 2 diabetes.20 For purposes of this 
study, then, the Hispanic population will include all population sub-groups that are typically 
associated with the terms “Hispanic” and “Latino.” 
In addition, there is much debate in Hispanic/Latino communities about which term 
(“Hispanic” or “Latino”) is more appropriate and acceptable, as each has political, social and 
generational connotations.  The vast majority of the sources tapped for this work used the 
term “Hispanic.” For the sole purpose of remaining consistent with those published sources, 
this study will also use “Hispanic.”   
Finally, incidence reduction was chosen as an objective to maximize the value and 
impact of the intervention(s).  The promise of incidence reduction, after all, is the avoidance 
of disease -- and its human and economic toll -- altogether.b   
There is one critical underlying assumption on which this study is based:   Racial and 
ethnic health disparities persist even when socioeconomic status, insurance coverage and 
ability to pay are not factors.  Furthermore, racial and ethic differences in patient 
                                               
b While the primary objective will be to examine incidence reduction, both prevalence and incidence reduction 
techniques will be considered, as both may be applicable to the goals of this study. 

 
 
 
 7 
preferences, care-seeking behaviors, and attitudes toward care do not fully explain health 
disparities.  Instead, key drivers of disparities are present in the operation of healthcare 
systems and the clinical encounter.  (Recall that this is the theory posited by the Institute of 
Medicine, and is one that is reflected thematically in much of the more current research on 
the drivers of racial and ethnic health disparities.) 
 
Benefits of this Research 
To answer the question, “Is there a role for private payers in reducing the incidence 
of type 2 diabetes among U.S. Hispanics,” this study summarizes methods employed by 
health plans or other organizationsc that are designed to accomplish any one of the 
following:   
 Reduce the incidence of diabetes 
 Provide more effective care to groups (such as Hispanics) that may experience 
barriers to care as a function of gaps in health care operations and the clinical 
encounter  
 Specifically address the health disparities experienced by Hispanics 
 Reduce the incidence of any health condition(s) among Hispanic 
 Reduce the incidence of diabetes among Hispanics 
 
This project uniquely integrates findings from three sources:  peer-reviewed 
literature, payer industry findings (report summaries, reports, articles, press releases, 
presentations, toolkits, conference proceedings, web-based audio-visual presentations and 
web pages), and qualitative data and conclusions from key informant interviews held with 
                                               
c Other organizations include government payers, health care providers, employers, third party administrators, or 
any other player that can and does have influence over the funding or delivery of health care. 
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subject matter experts at organizations planning, implementing or currently executing 
programs aimed at reducing health disparities in Hispanics with diabetes.   
This study also includes a discussion and evaluation of outcomes data or other 
evidence provided by the evaluated programs that indicates success against its stated 
objective(s).  Examples of such markers include reduced incidence of diabetes for Hispanics 
and/or other populations, indications of improved care for Hispanics or groups that typically 
experience disparities in health outcomes, and reduced incidence of any health condition(s) 
among Hispanics. 
This integration of existing and new information will provide health plans and other 
organizations interested in reducing the racial and ethnic disparities in health and health 
care for Hispanics with diabetes with a consolidated source of insights into the design, 
objectives, challenges, successes, results and lessons learned by other organizations that 
have undertaken such initiatives. 
 
Product of this Research:  A Plan of Action 
This project provides a specific plan of action for health insurers interested in 
reducing racial and ethnic health disparities among Hispanics with diabetes.  This plan of 
action is built on the detailed summary and outcomes review, and consists of recommended 
actions, or “promising practices” for health insurers or other organizations to take to reduce 
gaps in diabetes care and outcomes among Hispanics in the United States.   
 
 
 
 
CHAPTER 2:  REVIEW OF THE LITERATURE 
 
The focus of this study is to identify successful and, in particular, replicable payer 
intervention strategies to reduce the incidence of diabetes among Hispanics.  Population 
health management programs are one promising payer-based solution that may provide 
important insights into the crucial intersection of health improvement for specific populations 
and payer strategies for doing so.    
Population health management differs from traditional disease management in 
several key ways.  First, these programs focus on the whole person and that person's 
propensity to develop one or more diseases (as opposed to a particular disease or 
condition).  In addition, they encompass more types of illnesses than typical disease 
management programs, and consider both chronically ill and high-risk healthy patients (as 
opposed to traditional disease management that focuses solely on chronically ill patients).  
Finally, population health management programs apply the concept of “one stop shopping,” 
in which patients with multiple conditions are managed through a single point of contact and 
coordination. 
Such programs pose interesting questions for this study.  What diseases and 
populations do population health management programs address?  Where have they 
succeeded or failed in reducing disease incidence and health disparities, and why?  What 
lessons do they offer for future payer interventions to address racial and ethnic health 
disparities?     
To answer these questions, a systematic review of the literature was conducted, 
using formal methods of literature identification, selection of relevant articles, information 
abstraction, and synthesis of results, to determine the mechanisms that have been identified 
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as possible solutions for racial and ethnic health disparities, define the mechanisms 
employed by population health management programs, and measure the success (or lack 
thereof) of such programs. 
The review was performed in February of 2007 by searching:  (1) MEDLINE®, (2) the 
Cumulative Index of Nursing and Allied Health Literature (CINAHL®), (3) The Cochrane 
Library®, and (4) Academic Search Premier®.  In addition, the American Journal of Managed 
Care was identified as a priority journal (based on the number of citations produced in the 
database search), and the tables of contents for issues from 2001-2007 were scanned for 
relevant articles.  Reference lists of key review articles from the database search were also 
scanned, and “snowballing” (reviewing lists of related articles) from the original database 
search return lists was also employed. 
The results of the searches were imported into EndNote X©, a reference 
management software program.  The software was used to identify/remove duplicates and 
store citations and abstracts.   
 
Definitions 
Population health management programs were defined as programs that:  1) Focus 
on the whole person and that person's propensity to develop one or more diseases (as 
opposed to a particular disease or condition); 2)  Encompass more types of illnesses than 
typical disease management programs;  3)  Consider both chronically ill and high-risk 
healthy patients (as opposed to traditional disease management that focuses solely on 
chronically ill patients);  and 4)  Apply “one stop shopping,” in which patients with multiple 
conditions are managed through a single point of contact and coordination.13 The term racial 
health disparity was defined as ‘racial or ethnic differences in the quality of healthcare that 
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are not due to access-related factors or clinical needs, preferences, and appropriateness of 
intervention.’5   The terms race and ethnicity were used interchangeably and defined as all 
non-white or non-Caucasian ethnicities, including Asian/Pacific Islander, American 
Indian/Native American/Alaskan Native, Hispanic and African American.  
 
Eligibility Criteria for Database Search and Title/Abstract Review 
 The following criteria were used to exclude articles:  published prior to 1999 (for 
relevance, currency and volume control), did not take place in the United States, did not 
include human data, did not provide a full article, and were not written in English.    
For the set of possible solutions for racial health disparities, the database search 
terms originally included the terms racial, disparities or inequalities and interventions or 
solutions. That method of search resulted in a substantial number of articles; subsequent 
searches narrowed the criteria to include research specific to drivers of diseases or 
conditions typically addressed by disease or population health management programs 
(chronic obstructive pulmonary disease – COPD, diabetes, ischemic heart disease, asthma, 
heart failure, and obesity/overweight).   
For the interventions employed by population health management programs, the 
search term population health management was used.  Unfortunately, as these programs 
are nascent, the only available information describing mechanisms and evaluating outcomes 
was published by commercial organizations marketing such programs to payers.  The 
search was then modified to include the more established term disease management. 
Titles and abstracts were then reviewed for relevance.  Articles that did not directly 
address possible interventions or solutions to health disparities, or that examined diseases 

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or conditions outside those typically addressed by disease management or population 
health management programs were excluded.   
Article Review 
Each remaining article was reviewed against the following criteria:  (1) it included a 
specific, actionable, and repeatable solution or intervention; (2) the solution or intervention 
included an evaluation or measurement of its efficacy, not just a description of the program; 
and (3) the solution or intervention was within the realm of influence of disease management 
or population health management programs.  For an article to be considered eligible, it had 
to meet all three inclusion criteria. 
The realm of influence for disease management or population health management 
was defined as one or more or the following areas:  population identification processes; 
evidence-based practice guidelines; collaborative practice models to include physician and 
support-service providers; patient self-management education (may include primary 
prevention, behavior modification programs, and compliance/surveillance); process and 
outcomes measurement, evaluation, and management; routine reporting/feedback loop 
(may include communication with patient, physician, health plan and ancillary providers, and 
practice profiling).21    
 
Results 
Results of the literature search and review process are summarized in Figure 2.  The 
search criteria initially yielded a total of 431 articles; of these, 158 qualified for title and 
abstract review.  Only seven articles, including one literature review, met all three of the 
inclusion criteria outlined above. 
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Figure 2:  Summary of Literature Search and Review 
 
 
 
Table 1 provides a summary of key article characteristics.  All studies were published 
between 2004 and 2006.  Study settings included managed care plans, primary care 
facilities, and disease management programs.  (The systematic review considered multiple 
settings.)   The majority of the articles focused on diabetes; heart disease, preventive care 
and multiple conditions (from the systematic review) were also considered.   
In terms of interventions, the majority of studies (n=4) examined outcomes in 
managed care or disease management programs.  One article compared diabetes patient 
status outcomes between managed care and traditional care in a mixed minority population, 
and another examined the differences in outcomes for minority patients receiving care 
delivered by a nurse following diabetes-specific treatment algorithms versus those who 
received usual care from doctors.  The authors of the literature review included in this 
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analysis found that 25 of the 27 articles that qualified for inclusion focused on the 
patient/physician encounter.   
 
Table 1:  Summary of Studies 
  Number of Studies
Publication Date 2004 
2005 
2006
2 
3 
2
Study Setting Various 
Managed Care Plan 
Primary Care Setting 
Disease Management Program
1 
3 
2 
1
Disease or Condition Diabetes 
Heart Disease 
Preventive Cared 
Multiple
4 
1 
1 
1
Intervention Patient Participation in Managed Care  
Disease or Case Management  
Use of Treatment Algorithms 
Various
3 
2 
1 
1
Patient Ethnicity All Non-White 
African American 
Hispanic
3 
3 
1
Evaluation or 
Measurement  
of Efficacy
Patient Health Status 
Healthcare Process 
Patient Ratings of Care
7 
2 
1
 
 
Most studies examined the differences between white and all non-white or non-
Caucasian populations (n=3) or between white and African American populations (n=3).  
One study examined Hispanics.   All but one study used one or more measures of patient 
health status (A1C levels, LDL levels, blood pressure levels, functional status or quality of 
life) as the evaluation or measurement of the intervention’s efficacy.  Two articles examined 
healthcare process.  The literature review considered patient ratings of care, in addition to 
patient health status and healthcare process, as an outcome measurement. 
 
                                               
d As measured by influenza vaccination, mammography and prostate-specific antigen screening. 
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Table 2:  Summary of Interventions and Outcomes 
Intervention(s) Disease or 
Condition
# 
Studies
Outcome Assessment
 
Managed Care 
Program
 
Preventive Care 
Diabetes
 
1 
2
Mixed 
Participation in managed care did not 
narrow racial differences between blacks 
and whites in preventive care. 
In one study, racial differences in 
diabetes control did not diminish over 
time; another found that race/ethnicity 
was not consistently associated with 
worse processes or outcomes and that 
not all differences favored whites.
 
Disease 
Management 
Program
 
Diabetes 
Heart Disease
 
1 
1
Favorable 
Glycemic control was substantially 
improved in the low-income, ethnic 
minorities.  Differences in functional 
status between whites and blacks 
disappeared over time.
 
Use of 
Treatment 
Algorithm by RN
 
Diabetes
 
1
Favorable 
Nurses making clinical decisions based 
on detailed treatment algorithms in a 
minority population did a better job of 
achieving recommended process and 
outcome measures than did physicians 
providing usual care.
 
Various, but 25 
of the 27 articles 
reviewed 
focused on the 
patient/physician 
encounter
 
Various
 
1
Favorable 
All but two of the 27 reported favorable 
outcomes; the two that did not 
demonstrate improvement were also 
rated as being of poor quality by the 
authors.   Ten studies examined tracking 
and/or reminder systems, all with positive 
results.
 
Managed Care Programs 
Outcomes assessments from the managed care studies were mixed.   One study 
examined preventive care use (influenza vaccination, mammography and PSA test 
utilization) among adults aged 65 years and older, comparing rates between those enrolled 
in a Medicaid managed care program and a fee for service program.  This study found no 
                                               
e As measured primarily by appropriateness of care. 
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significant differences among blacks and whites between the programs, concluding that the 
managed care program in this case did not narrow racial differences in preventive care.22 
Another longitudinal study of managed care examined differences in diabetes 
outcomes over 4-8 years for black versus white members of a single HMO, as measured by 
HbA1c levels.  The analysis found that racial differences in diabetes control did not diminish 
over time, leading the authors to conclude that factors other than quality of care were to 
blame for the persistent racial differences in HbA1c levels.  These findings were in contrast 
to the authors’ initial hypotheses that such differences would diminish over time due to 
standardization of care, and that there would be few or no racial differences among patients 
with newly diagnosed diabetes (due to the consequences of improved quality of care in the 
later years of the study.)23   
  The third managed care study reviewed for this analysis examined the effects 
of race, ethnicity, socioeconomic position and quality of care for adults with diabetes 
enrolled in managed care.24  By assessing a wide range of process of care assessments 
(HbA1c, [A1C], lipid and proteinuria assessment; foot and dilated eye examinations; use or 
advice to use aspirin; and influenza vaccination) and patient health status (HbA1c, LDL and 
blood pressure control) among five racial/ethnic groups, the authors concluded that 
belonging to a minority ethnic group (being non-white, in this case) was not consistently 
correlated with worse processes or outcomes.  In addition, the study found that not all 
differences in processes or outcomes between race/ethnic groups favored whites. 
 
Disease Management Programs 
Two studies examined the impacts of disease management programs on healthcare 
disparities; both reported positive impacts on health disparities as a result of participation in 
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such programs.  Both programs involved extensive interventions, including risk identification 
and stratification; the application of evidence-based practice guidelines and algorithms; 
identification of potential barriers to care; development of culturally and linguistically 
appropriate individualized treatment and education strategies (including monitoring of 
appointments and rescheduling of those that were missed and provision of transportation to 
improve visit completion); and centralized, active coordination of care (including 
identification of necessary ancillary medical services, follow-up to ensure receipt of services, 
and results retrieval and reporting to the primary care provider). 
The first study, a before-after cohort study, examined differences in quality of life and 
functional status between blacks and whites with heart disease over a two-year period.25  
The authors concluded that quality of life disparities did not exist between blacks and whites, 
either at baseline or over the course of the study, but that functional status differences, 
present at baseline, did disappear over time. 
The second study, a case-control trial, evaluated HbA1c differences in a low-income 
minority population (>55% minority representation) between participants and non-
participants in a diabetes case management program over a two-year period.26  The authors 
found substantial improvements in glycemic control for the participant group and concluded 
that diabetes case management can help reduce disparities in diabetes health status among 
low-income ethnic populations.  This study did not examine outcome differences between 
racial or ethnic groups. 
 
Registered Nurse (RN)-Administered Treatment Algorithms 
 One study isolated the impacts of the administration of diabetes treatment algorithms 
by registered nurses in a Hispanic population, asserting that most diabetes disease 
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management programs had a “modest” effect on glycemic control.27  After one year, the 
authors concluded that nurses simply following detailed treatment algorithms under the 
supervision of an endocrinologist had a significant and positive impact on glycemic control, 
even in a poor and poorly educated minority population. 
 
Literature Review of Provider Interventions 
 Finally, the literature review included in this study evaluated the impact of 
interventions targeted at health care providers on health care quality for racial/ethnic 
minorities.28   The authors performed a systematic review of articles published between 
1980 and 2003, and found that, of the 27 studies meeting the review criteria, 25 reported 
favorable outcomes.  Ten studies examined tracking/and or reminder systems, forming the 
largest base of studies for a single type of intervention.  All ten studies demonstrated 
positive outcomes (as measured primarily by appropriateness of care).  Interestingly, 
however, the study notes that only two articles were specifically targeted at addressing 
racial/ethnic healthcare disparities; all others were generic quality improvement strategies (a 
finding echoed by this analysis).   
 
Discussion  
This review attempted to identify successful, measurable intervention strategies 
designed to reduce racial/ethnic health disparities.  The original objective was to examine 
the impact of population health management programs; given their proactive stance, 
broader disease focus and patient-centric approach, they seemed to provide a promising set 
of potential solutions.  Their nascence, and the resultant lack of evidence surrounding their 
impact on health outcomes, however, required the search to be broadened to include more 
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traditional disease management programs and any type(s) of patient or provider education 
or intervention.  Even so, only seven studies that both specifically addressed disparity 
reduction strategies and reported measurable results were found.f  
 
Summary of Findings 
All seven studies reported mixed or favorable results (based on health outcomes).  
While simply participating in a managed care plan or program does not seem to provide 
better outcomes for racial and ethnic minorities, disease management programs, use of 
treatment algorithms administered by registered nurses, and targeted health care 
interventions in the primary care setting do hold some promise for reducing or eliminating 
health disparities.   A common theme that begins to emerge is that the application of 
treatment algorithms and tracking and/or reminder systems seem to be effective at reducing 
health disparities, but the body of research examining and measuring even this limited set of 
potentially successful interventions is as yet too small to draw any valid conclusions.   
Against the backdrop of the entire health care delivery process, and the broad array of 
potential strategies to reduce racial/ethnic health disparities that it presents, the knowledge 
base is indeed extremely limited. 
Research examining cost or performing cost/benefit analyses is even more sparse 
than that which addresses intervention strategies and outcomes.  Most organizations have 
resource constraints and therefore allocate those scarce resources to programs or initiatives 
that show some evidence of efficacy; the successful adoption of strategies to reduce racial 
and ethnic health disparities will rely on their cost, feasibility and ability to measurably 
improve outcomes.  In none of the six specific studies was cost considered or measured; in 
                                               
f For purposes of this discussion, the literature review may be referred to as one study or may be disaggregated 
into its 27 component studies.  The latter approach will be used to highlight specific finding(s) useful to this 
analysis. 
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the provider intervention literature review, only one of the 27 studies cited costs – in this 
case, for a renal insufficiency case management program (for which no health benefits were 
found).    
The health disparity knowledge gap extends to specific populations.  Most studies 
focused on white vs. all non-white populations or on white vs. black populations; only three 
of the 33 (including the 27 contributed by the literature review) separately examined 
Hispanic populations and none addressed Asian/Pacific Islander or American 
Indian/Alaskan Native populations.   
 
Implications for Future Research 
More focused research examining and evaluating strategies for reducing racial/ethnic 
health disparities is needed.  Specific recommended areas of study include determining 
which strategies for reducing healthcare disparities are most effective; examining the costs 
of such strategies; evaluating the impacts of interventions in Hispanic, American 
Indian/Alaskan Native or Asians/Pacific Islander populations; and assessing patient 
outcomes as opposed to healthcare process (and determining the linkages between the 
two).     
This will be no easy task:  As this review found, vast differences in diseases and 
programming, and the lack of standardization within and across studies will make any 
conclusions difficult to draw and the reliability of such conclusions even more challenging.   
Outcomes are impacted by a large number of variables, including the type of disease or 
condition, the number and types of components of the intervention strategy, the 
administration of the strategy (e.g., incentives for the participants and/or providers, methods 
of assuring that planned actions do in fact occur, etc.), program enrollment/study population 
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(population size, density, geography, ages, co-morbidities, socioeconomic status, etc.), the 
quality of the program or intervention, and the outcome measure itself.  In the latter case, for 
example, how does a lower glycemic index compare to enhanced functional status for a 
diabetic?  Which one is considered the better outcome?  Finally, it is reasonable to expect 
different responses, and therefore different outcomes, by unit of analysis (e.g., by 
community, by particular race/ethnicity, by individual, etc.). 
 
Limitations 
The limitations of this review are inherent in the number of articles that ultimately met 
the search criteria, even after the original constraints were relaxed to include less stringent 
definitions of strategies or interventions.  Possible future modifications to expand the 
number of studies qualifying for review include the consideration of articles published prior 
to 1999, as well as those that took place outside the United States.  In addition, no rigorous 
quality evaluation or scoring was conducted as part of this review, in large part due to the 
paucity of material found.  Articles were deemed of sufficient quality on the basis of their 
publication in reputable journals; future research should include a measure or score of 
evidence quality. 
 
  
CHAPTER 3:  METHODS 
 
Description of Conceptual Model 
This study involves the evaluation of the interactions between the three key 
stakeholders in the delivery of health care – the payer, the provider and the member/patient 
(see Figure 3).   Specifically, this study examines current practices within the realm of payer 
influence, as well as opportunities for intervention methods that actually succeed in, or show 
promise to, reduce health disparities in diabetes amongst Hispanics in the U.S. in three key 
areas: 
1. Interactions between payers and members, including disease and health 
management programs, treatment and place of service incentives and disincentives 
for patients (as provided by their benefit plan design), community outreach programs, 
health coaches, and information designed to improve patients’ self-care.  These are 
referred to as “payer-member interventions” in this study. 
2. Interactions between payers and providers, including provider scorecards which 
measure quality of care, programs which reward providers for desired outcomes – 
“pay for performance,” and treatment algorithms.   These are referred to as “payer-
provider interventions” in this study. 
3. Interactions between providers and members, including the provision of culturally 
and linguistically appropriate services, and other methods designed to improve the 
effectiveness of the clinical encounter for Hispanics.  These are referred to as 
“provider-member interventions in this study. 
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Figure 3:  Conceptual Model for Evaluating Potential Private Payer Interventions to 
Reduce the Incidence of Diabetes Among Hispanics in the United States. 
 
Study Design 
This study employed qualitative research methods, in a two-part model.  The first 
component, a “best practices” document review, was performed to examine existing 
interventions employed within the private payer industry.  The document review served two 
primary purposes:  it broadened the scope of the original literature review beyond peer-
reviewed journals to include commercial and government information sources, and it 
assisted in the identification of organizations and individuals to tap for key informant 
interviews.   
In addition, the study included key informant interviews involving subject matter 
experts at health insurance companies implementing diabetes or racial/ethnic health 
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disparity intervention programs.  The objective of these interviews was to develop a more 
detailed understanding of the objectives, drivers, structure, effectiveness, level of 
organizational commitment, and lessons learned from the development and implementation 
of the programs – and to tap into any information not readily available through public access 
means. 
 
Data Collection 
Document Review 
The document review consisted of a Google web search in August of 2008, using 
the following combinations of terms: 
1. Health insurer OR insurer OR payer AND  
2. Diabetes AND 
3. Hispanic OR Latino AND 
4. Disparities AND 
5. Interventions OR methods OR strategy 
6. NOT blog 
 
The search was restricted to results from the United States, published in the English 
language, and those that were updated within the past year.   
A total of 1,410 results were returned in the original search.  Results were initially 
reviewed to identify sources cited more than once in the results and health insurance 
organizations mentioned in association with these search terms.  To augment this strategy, 
references and reference lists from sources identified via the web searches were reviewed.   
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The types of documents reviewed included report summaries, reports, articles, press 
releases, presentations, toolkits, conference proceedings, webinars (web-based audio-
visual presentations) and web pages.  They were obtained primarily via direct downloads 
from websites and electronic journals; in some instances, documents were received directly 
from the author or original source (as in the case of unpublished documents). 
All documents that involved Hispanic or Latino racial and ethnic categories, diabetes, 
and interventions that encompassed interactions between payers and providers, payers and 
members/patients, or members/patients and providers were included.  Interventions at the 
community level were also included, in an attempt to examine additional interventions that 
may be of potential value for payers to consider.  Any documents that described 
interventions of any type that took place outside the United States were excluded. 
 
Figure 4.    Summary of Document Search and Review 
 
Results of the document search and review process are summarized in Figure 4.  A 
total of 72 documents, including three meta-analyses of 92 studies, met the qualifications 
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outlined above.  The primary sources from which documents examined for this portion of the 
research are summarized and described in Chapter 4.g 
 
Key Informant Interviews 
The selection of health plans for participation in the key informant interviews was 
based on purposeful sampling.   First, the organization was selected for inclusion in the 
sample if it was determined during the document review that it has either implemented or is 
in the process of implementing a program or programs to improve the overall health of the 
organization’s Hispanic population.  The program(s) could be focused on Hispanics only or 
specifically on Hispanics with diabetes.  Within that population, health plans were 
specifically recruited to ensure representation across three categories:  geographic 
coverage (national, regional, and local, as defined below); organizational type (for-profit and 
not-for-profit); and delivery system type (integrated and contracted).   These categories, 
which are described below, generally serve as key differentiators between health insurance 
plans in terms of geographic reach, variability of markets served, resource availability, 
marketplace pressure on profitability, and the organization’s level of control over its delivery 
system – in other words, its care providers and facilities.  While the sample size is not large 
enough to draw definitive conclusions about these differentiators and how they might play a 
role in each organization’s efforts to reduce health disparities, the inclusion of organizations 
that represent each one of these variables provides for a more representative sample of the 
health insurance industry. 
 For purposes of this study, the term “national health plan” means that the 
organization markets and services health insurance coverage in ten or more states.  A 
                                               
g Documents include report summaries, reports, articles, press releases, presentations, toolkits, conference 
proceedings, webcasts (web-based audio-visual presentations) and web pages. 
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“regional health plan” is an organization operating in more than one state and less than ten.  
A “local health plan” operates in one state or less.  Health plans were classified for the study 
without the inclusion of national accounts (such as Interplan Programs or IPP, for Blue 
Cross and Blue Shield plans), in which a local, regional, or national health plan has a 
national presence by virtue of cooperative claims processing and network usage 
arrangements with other payer(s) in other states. 
This study also uses the accepted, widely published definitions of not-for-profit or 
non-profit and publicly traded.  A not-for-profit or non-profit organization is an incorporated 
organization in which no stockholder or trustee shares in profits or losses, and it usually 
exists to accomplish some public, charitable, humanitarian, or educational purpose. A for-
profit organization is one that is established or operated with the intention of making a 
profit.29  
 In a contracted network arrangement, hospitals, physicians and other health care 
providers engage in a contractual arrangement with the health plan to provide services, 
usually for a set fee, based on procedure codes (known as a fee schedule).  Contracted 
entities are also obliged to meet certain criteria to remain in the network of providers and 
facilities.  However, the contracted entity (or the health insurance plan offering the contract) 
may terminate the relationship as allowed by the specific contract between the two entities.   
An integrated delivery system (IDS) is a network of health care providers and 
organizations that provides or arranges to provide a coordinated continuum of services to a 
defined population and is willing to be held clinically and fiscally accountable for the clinical 
outcomes and health status of the population served.   Services provided by an IDS can 
include a fully-equipped community and/or tertiary hospital, home health care and hospice 
services, primary and specialty outpatient care and surgery, social services, rehabilitation, 
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preventive care, and health education and financing, usually using a form of managed 
care.30    
Fifteen organizations were ultimately included in the sample.  Potential respondents 
were selected for participation on the basis of their responsibilities related to either the 
implementation or ongoing oversight of such program(s) and were invited by email to 
participate in 60-minute semi-structured telephone interviews.  As part of the invitation, 
respondents were informed that the purpose of the interview was to develop a deeper 
understanding of the mechanisms – both current and potential – that health insurers are 
using or may use to help address health disparities in diabetes between Hispanics in the 
United States and white Americans. 
Recruitment continued until a representative of an organization refused to 
participate, or until three consecutive contact attempts went unanswered.   Contact was 
initiated via email; non-respondents were then telephoned and sent a follow-up email. 
Eight of the fifteen (53%) organizations invited participated in the key informant 
interviews.   Of the seven organizations that were not included in the study, one explicitly 
refused to participate (citing advice of internal legal counsel), four did not respond to any of 
the email and follow-up voice mail requests, and two were unable to schedule the necessary 
individual(s) during the interview phase of this study. 
Table 3 provides an overview of the distribution of both participating and non-
participating health plans across the three categorical variables of geographic coverage, 
organizational status, and type of delivery system.  Both participating and non-participating 
plans were evenly distributed across the geographic and organizational status categories.  
In the only notable difference between the participating and non-participating groups, both of 
the health plans with integrated delivery networks elected to participate in the study.   There 
do not appear to be any material difference between the two groups that might impact study 
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results or suggest any bias; however the inclusion of two integrated delivery systems does 
allow for some comparisons between contracted and integrated delivery systems in the 
participant group. 
 
Table 3:  Categorical Descriptions of Health Plans Included in Key Informant Interview 
Sample, By Participation Status 
Health Plan Geographic 
Coverage 
Organizational 
Status 
Type of Delivery 
System 
Participated in 
Study? 
Health Plan #1 Local Not-for-Profit Contracted Y 
Health Plan #2 Local Not-for-Profit Contracted Y 
Health Plan #3 Local Not-for-Profit Integrated Y 
Health Plan #4 Regional  Not-for-Profit Integrated Y 
Health Plan #5 Regional Not-for-Profit Contracted Y 
Health Plan #6 National  For-Profit Contracted Y 
Health Plan #7 National  For-Profit Contracted Y 
Health Plan #8 National For-Profit Contracted Y 
Health Plan #9 Local Not-for-Profit Contracted N 
Health Plan #10 Local Not-for-Profit Contracted N 
Health Plan #11 Regional  For-Profit Contracted N 
Health Plan #12 Regional Not-for-Profit Contracted N 
Health Plan #13 Regional  For-Profit Contracted N 
Health Plan #14 National For-Profit  Contracted N 
Health Plan #15 National  For-Profit Contracted N 
 
A total of ten individuals at eight organizations were interviewed.  All key informants 
came from either the marketing division or the health care division.  In a health plan, the 
marketing division is typically responsible for marketing, sales and enrollment functions.  
These functions include market research, product development, prospecting, sales and 
enrollment of new and renewing members into the plan of coverage selected or purchased.   
The health care division is usually responsible for disease and population health 
management programs, utilization management, case management, care quality 
improvement programs, provider credentialing, medical policy and member and provider 
appeals.   This division employs clinical personnel, such as physicians (typically as medical 
directors) and nurses (usually as case managers and health coaches). 
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Interviews took place from October to December of 2008.  Due to the geographic 
spread of key informants and the cost parameters of this study, interviews were conducted 
by telephone.  They were recorded using Audacity (version 1.2.5), an open-source digital 
audio editor, and transcribed into Microsoft Word 2004.   
See Appendix A for the key informant interview guide.  The guide was pre-tested by 
three individuals with roles similar to those of the key informants prior to the first interview.  
Interviews were semi-structured; the script was modified both before and during the course 
of the interview.  Modifications made before the interviews were based on information 
gained during the document review about the relevant programs the health plan had in 
development or underway.  The objective of these changes was to target the questions to 
produce more specific information about the program(s).  Those modifications made during 
the course of the interview were based on the participant(s)’ responses to the preceding 
questions.   
 
 
Data Analysis 
Both primary data (from the key informant interviews) and secondary data (from the 
document review) were collected for this study.  The information obtained from the key 
informant interviews was primarily qualitative.  In some cases, organizations had performed 
internal quantitative analyses of their program; any such data made available by that 
organization was also included in the study as secondary data.   In addition, information 
specific to any one organization and its health disparities reduction efforts, programs and 
initiatives gathered in the document review was validated in the key informant interviews.   If 
the information was valid, it was used for triangulation and data enrichment purposes.   
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The interview recordings and transcriptions were reviewed to identify themes and to 
compare and contrast responses across interviews. In addition, themes such as “multi-
factorial interventions” that were illuminated by the initial document review were included as 
a component of the analytical framework.  Themes were coded and, where possible and 
appropriate, counted and weighted by frequency of mention or extent of treatment.  Extent 
of treatment was measured by counting lines of text in the transcription.  Finally, themes 
were grouped for discussion and conclusion purposes. 
 
  
 
CHAPTER 4: DOCUMENT REVIEW FINDINGS 
 
Description of Sources 
The Center for Health Care Strategies (CHCS) is a nonprofit health policy resource 
center dedicated to improving the quality and cost effectiveness of health care services for 
low-income populations and people with chronic illnesses and disabilities. The Center works 
directly with states and federal agencies, health plans, and providers to develop programs to 
better serve people with complex and high-cost health care needs; its activities focus on 
three primary priorities, one being the promotion of national efforts to reduce racial and 
ethnic disparities.31  The CHCS website includes a wide array of resources, including 
webinars, journal articles, case studies, meeting highlights, technical assistance tools, and 
policy and issue briefs. 
The CHCS is also a key player in two important collaborative efforts specifically 
aimed at reducing racial and ethnic health disparities.  These two initiatives involve ten 
commercial health insurers (the National Health Plan Collaborative) and twelve Medicaid 
stakeholder organizations (the Improving Health Care Quality for Racially and Ethnically 
Diverse Populations Workgroup).  Both groups have published several reports, toolkits and 
technical assistance tools that address both health disparities in general, as well as 
disparities specific to Hispanics with diabetes. 
Other important sources for documents included the following websites:  RAND 
Health, Pew Hispanic Center, the Robert Wood Johnson Foundation, the Agency for 
Healthcare Research and Quality (AHRQ), the Institute for Healthcare Improvement (IHI), 
the Kaiser Family Foundation, the American Medical Association (AMA), the National 
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Quality Forum (NQF), the National Committee for Quality Assurance (NCQA), the American 
Diabetes Association (ADA), the National Business Group on Health (NGBH), and various 
health plan websites. 
In addition, trade publications, such as Best’s Review, Managed Care, Health Affairs, 
and Managed Care Quarterly were reviewed for relevant articles.  Sources at the Blue Cross 
and Blue Shield Association, which has a multi-plan committee focused on the reduction of 
healthcare disparities, were also contacted; several documents were made available by the 
head of that committee. 
Finally, three meta-analyses, or systematic reviews, of interventions designed to 
reduce health care disparities that contained information about diabetes were included.  
These papers were published in Medical Care Research and Review after the original 
literature review was performed in February of 2007.32-34  Relevant findings from the 
individual studies included in the meta-analyses are discussed below. 
 
Key Findings 
The National Health Plan Collaborative (NHPC), originally formed in December of 
2004, now includes ten major health insurers that cover 87 million members -- almost half of 
commercially insured Americans and several millions served by Medicare and Medicaid.   
Current members include Aetna, CIGNA, Harvard Pilgrim Health Care, Highmark, Inc., 
Humana, Kaiser Permanente, Molina Healthcare, UnitedHealth Group, and Wellpoint, Inc. 
The NHPC is managed and coordinated by the Center for Health Care Strategies, in 
coordination with the RAND Corporation, with funding and leadership support from the 
Agency for Healthcare Research and Quality (AHRQ) and The Robert Wood Johnson 
Foundation.  Its stated mission is as follows: 
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“We have come together because we are committed to reducing racial and ethnic 
health disparities and improving the quality of care all Americans receive. While 
others in America’s health care system—purchasers, patients and providers—also 
have critical roles to play, this effort by health insurance companies is a way to do 
our part to solve this unacceptable problem. For more than 20 years, research has 
documented persistent gaps in health care quality that disproportionately affect 
Americans from specific racial and ethnic backgrounds. In 2002, the Institute of 
Medicine specifically identified the need for health insurance companies to collect, 
report and monitor patient care data to build a foundation for solutions to the 
problem of racial and ethnic disparities in care. The Institute of Medicine’s 
recommendation spurred us to action. Through this collaborative, we believe we are 
making a positive difference in closing the gaps in health care quality.”35  
 
The organization has adopted a four-level framework for considering interventions to 
reduce racial and ethnic health disparities.36 Activities rest on a foundation of having data on 
enrollee race/ethnicity with which to examine disparities.  Figure 5 depicts the framework 
and the steps involved; the bi-directional arrows refer to collaborations with the array of 
partner activities necessary to support plan efforts at reducing disparities.   
 
Figure 5:  National Health Plan Collaborative Four-Level Framework for Considering 
Interventions36 
 
QI refers to quality improvement, while IT refers to information technology. 
 
The NHPC has engaged in a two-phased effort.  In Phase One (2004-2006), 
member health plans focused on the collection of member race/ethnicity data and the 
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Table 4:  Summary of National Health Plan Collaborative (NHPC) Plan Disparity 
Reduction Activities36 
Plan Method of Obtaining 
Member Race/Ethnicity 
Data 
NHPC Pilot Interventions Other Activities 
Aetna Direct, voluntary 
collection from members 
(have data on 
approximately 4 million 
members) 
Culturally tailored disease 
management, translation services, 
exploration of role of health literacy 
Direct to member outreach around 
mammography and prenatal care 
CIGNA Indirect methods; also 
has implemented 
collection of individual-
level race and ethnicity 
and primary language 
spoken, on a voluntary 
basis 
In-depth analysis of correlates of 
disparities, disease management 
Health literacy activities in Memphis, 
Tennessee, and with the American 
College of Physicians 
Harvard Pilgrim 
Health Care 
Indirect and direct 
methods 
Community and member 
interventions to increase receipt of 
eye exams 
- Member intervention to reduce 
disparities in colorectal cancer (CRC) 
screening 
- Quality improvement grants to 
provider groups for disparities 
reduction initiatives in diabetes and 
CRC screening 
- Coordination with Harvard Pilgrim 
Foundation programs that fund 
disparities reduction efforts by 
community-based groups 
HealthPartners Direct collection at 
practice group levels 
Cultural competency tranining for 
providers, identification of clinics in 
need of additional translator 
services 
Engagement of many business 
leaders and community groups in 
disparities discussions – the 
speaker’s bureau reached more than 
5,000 people in 2006 
Highmark, Inc. Indirect and direct 
methods 
Provider education in practices with 
higher than average minority 
members with identified gaps in 
care 
Reducing disparities has become part 
of Highmark’s 2007-2009 corporate 
strategic plan 
Kaiser 
Permanente 
Indirect methods Planning to implement pilot member 
educational intervention and 
universal prescription for aspirin-
lovastatin-lisinopril (ALL) in target 
region 
Extensive mapping to identify areas of 
highest yield for interventions 
Molina 
Healthcare 
From Medicaid offices - Nurse advice line offers 24-hour 
access to bilingual nurses, which 
increased outreach to members by 
direct telephonic contact in member-
preferred language 
- The diabetes disease 
management program provides both 
language- and culturally appropriate 
telephonic counseling. 
- The Molina Institute for Cultural 
Competency has been developed 
from the TeleSalud Project 
(originating from a Robert Wood 
Johnson Foundation Grant) to extend 
cultural knowledge and sensitivity 
- Distributed a cultural resource 
manual about language, culture, and 
religious sensitivity and understanding 
UnitedHealth 
Group 
Indirect measures and 
CMS data from prior 
research project 
Pilot test of provision of data on 
quality of care and race/ethnicity to 
physician practices 
- Multi-Cultural Organizational 
Assessment completed to promote 
the alignment of resources to meet 
the overall needs of the member 
population 
- Community Health “Centers of 
Excellence” initiative 
WellPoint, Inc. Indirect; direct measures 
from prior research 
project 
Disease management, changes in 
co-pay structure for diabetes testing 
supplies 
Examination of disparities among 
employee population; mapping to 
identify areas of highest yield for 
interventions; alignment of clinical, 
marketing and human resources 
responsibilities 
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examination of diabetes performance data for disparities.  During this phase, five plans 
implemented one or more pilot interventions to reduce racial and ethnic health care  
disparities.  These pilots are summarized in Table 4, along with a description of the 
method(s) used by each plan to collect member race and ethnicity data.   
There are two fundamental ways to collect member race/ethnicity data:  indirectly 
and directly.  Indirect techniques include the evaluation of language utilization data, geo-
coding, and surname analysis (with and without first name analysis), Geo-coding uses a 
member’s residence to approximate the likelihood of a member’s race or ethnic background; 
this technique is used primarily to identify enrollees who are likely to be African American.  
Surname analysis, typically used to identify Asian and Hispanic members, compares a 
person’s last name to a long list of surnames known to have a high probability of belonging 
to someone from the specified racial or ethnic group.37-39 
Direct data collection techniques include the use of mailed member surveys, paper 
and online enrollment forms, health risk assessments (HRAs), electronic medical records 
(EMRs) and online member services.  Other, less common, direct collection techniques 
include the evaluation of requests for translation and birth data.   Direct data collection 
techniques, while widely acknowledged as being more accurate, are also costly and slow. 
Pilot intervention activities among the Collaborative members varied widely, and 
included such methods as:  Culturally tailored disease management; language translation 
services; direct to member outreach around mammography, eye exams, colorectal (CRC) 
screening and prenatal care; quality improvement grants to provider groups for disparities 
reduction initiatives in diabetes and CRC screening; cultural competency training for 
providers; identification of clinics in need of additional translator services; changes in co-
payment structure for diabetic testing supplies; and many others.   

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Available results of the pilot interventions, as published by the NHPC, were largely 
positive (see Table 5).  Aetna, through intensified outreach to more than 500 African-
American and Hispanic members with diabetes and their physicians, succeeded in getting 
38% of non-adherent members to obtain both HbA1c and LDL-C screenings.  Diabetics in 
the intervention group also had better HbA1c control than those in the comparison group.  
Harvard Pilgrim held free retinal screening events in Hispanic communities with low 
screening rates; while attendance at the actual events was poor, 31% of Harvard Pilgrim 
members who received an associated outreach mailing did obtain an eye exam (compared 
to 26.5% of those in the control group).   Highmark launched an intervention in which 
physicians in practices with higher than average disparities in diabetic care sent letters to 
diabetic patients, reminding them to obtain needed testing; physicians have reported that 
the intervention is bringing targeted patients into their offices.   Molina Healthcare identified 
members with a stated preference for Spanish language and/or Hispanic ethnicity, and  
developed and distributed materials and conducted outreach specific to those members’ 
cultural norms; as a result, quality measures with respect to diabetes have improved, and 
members have experienced improvement in their diabetes management self-confidence and 
a coincident decrease in their program level of care requirements.40   
The National Health Plan Collaborative published its Phase One Summary Report in 
November of 2006.    At that point, the Collaborative had learned three key lessons, the first 
of which was that the size of health plans can be both an advantage and a disadvantage.  
Advantages come from the number of insured Americans and providers touched by member 
plans, and the awareness of health disparities that the Collaborative has been able to raise 
among the government, the health care community and the public at large.    Disadvantages 
come from the difficulty in gaining enterprise-wide support for disparities reduction across 
the large and diverse organizations that comprise the Collaborative. 
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The second lesson learned by the NHPC is that the collection of plan members’ 
racial and ethnic data, while politically sensitive, is both essential and feasible.  Education – 
both internal and external – is key.  Stakeholders must be told about the objectives behind 
data collection and be given assurances about how it will be used.  Member health plans are 
now collecting data from both primary and indirect sources, but the health care industry lags 
behind others, due in no small part to the absence of federal guidelines for the collection 
and disclosure of race and ethnicity data in health care quality improvement. 
The third and final lesson is that collective action is a key to progress in disparities 
reduction.  NHPC members have been able to raise understanding of the issue within their 
organizations, and they are learning from each other – what disparities are, what causes 
them, how to measure them, and how to reduce them.  Members also understand more fully 
the limitations of acting independently to address an issue that will require the action of all 
stakeholders in the health care system. 
In Phase Two (2006- 2008), the Collaborative focused on the collection of health 
plan members’ primary race, ethnicity and language preference data, improving language 
access, and the determination of the business case and ROI for disparity reduction. In 2007, 
the group published a toolkit with resources such as lessons learned, best practices and 
tools developed from the efforts of its member plans, in order to assist other health insurers 
wishing to address the issue of racial and ethnic health disparities.41  Topic areas include an 
introduction to healthcare disparities, the NHPC, and the toolkit; information about the 
collection of race, ethnicity and language preference data  (including a discussion of national 
and local policies on data collection, the importance of communicating the importance of 
data collection to stakeholders, guidance on categories of race/ethnicity to use, and an 
outline of member plan methods for collecting data); information about language access 
programs; and guidance for the development of a business case for improving quality and 
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addressing disparities.    Finally, the toolkit contains names and contact information for 
NHPC member plan representatives, one of the sampling sources for this study’s key 
informant interviews.40
The NHPC has now turned its attention to facilitating the collection of primary data 
by health plans.  The Collaborative is working to develop uniform approaches for collecting 
self-reported information about race and ethnicity, and it will seek the development of 
national guidelines for the collection and use of primary data in health care quality 
improvement.  The Collaborative is also working to enhance access for non-English 
speakers through a language translation services model that can be replicated by others in 
the industry, supporting investment in disparities reduction (primarily through the education 
of the CHCS), and sharing lessons learned with each other and the public.   
The Improving Health Care Quality for Racially and Ethnically Diverse Populations 
(IHCQREDP) Workgroup, a component of the CHCS’ Best Clinical and Administrative 
Practices initiative, is comprised of a total of twelve organizations, including eleven Medicaid 
health plans and one state primary care case management program.  Members include Blue 
Cross of California, HealthFirst (New York), Helix Family Choice (Maryland), L.A. Care 
Health Plan (California), Medica (Minnesota), Molina Healthcare (Michigan), Monroe Plan for 
Medical Care (New York), Neighborhood Plan of Rhode Island, Network health 
(Massachusetts), Oregon Collaborative, Oregon Department of Human Services, 
CareOregon, FamilyCare, Inc. (Oregon), Providence Health Plans (Oregon), SoonerCare 
PCCM (Oklahoma), and UPMC for You (Pennsylvania).  The initiative is managed by the 
CHCS and is funded by the Robert Wood Johnson Foundation and the Community Fund.42   
Workgroup members collaborated from 2004 to 2006 to develop new ways to 
identify members of racial and ethnic subgroups, to measure the gaps in care that these 
groups experience, and to explore ways to improve health care quality.  The workgroup 

 
 
 
 40
developed methods to uncover and address disparities in three targeted areas:  birth 
outcomes and immunizations, asthma care, and diabetes care.  Its toolkit, Reducing Racial 
and Ethnic Disparities:  A Quality Improvement Initiative in Medicaid Managed Care, was 
published in 2007, and includes key lessons in addressing disparities and several case 
studies in identifying and reducing disparities.38   
In that document, the workgroup outlined three key lessons in addressing disparities:  
collecting and analyzing data; designing patient-centered and culturally sensitive care; and 
encouraging collaboration to reduce disparities.  The first lesson echoes that of the National 
Health Plan Collaborative -- collecting data by race and ethnicity is a critical first step in 
identifying disparities in health care treatment and health outcomes, and in developing 
targeted strategies to address inequalities in care.38, 43-46  However, the workgroup found that 
there are a number of challenges and barriers to the collection and use of data on race and 
ethnicity to address health disparities, the primary one being data accuracy.  Accuracy 
problems stem from a lack of uniform standards in key categories like race, ethnicity, 
primary language, or country of origin; they also result from incomplete, missing or 
inaccurate data files transmitted from Medicaid agencies to Medicaid plans.  Further, 
enrollee self-reporting of race and ethnicity, while more accurate, is usually voluntary and 
typically results in large data gaps.  Finally, assignment of race and ethnicity based on 
indicators such as surname, geographic location, or physical appearance can also result in 
inaccuracies, particularly when members are multi-racial or multi-ethnic.  However, such 
indirect methods, while somewhat imprecise at the individual level, can provide an accurate 
estimate of the racial/ethnic differences in quality when analyzed at the population or group 
level.38, 39, 45, 47 
The second lesson, designing patient-centered and culturally sensitive care, 
stresses the importance of meeting the individual and cultural needs of plan members.  
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Recommended strategies include: one-on-one outreach to educate and motivate patients; 
seeking member feedback to strengthen commitment and adherence to medical regimens; 
and encouraging culturally competent contact between patients and doctors, through 
provider education, staff recruitment, staff training, translation services, and the 
development of linguistically and culturally appropriate health education materials. 
The third lesson, encouraging collaboration to reduce disparities, cites examples in 
which health plans that went beyond corporate confines to build creative relationships in 
their communities were able to reach members more effectively.  One health plan, UPMC for 
You, successfully partnered with community outreach representatives, social service 
agencies and local school districts to increase the number of women entering prenatal care 
during their first trimester and improve birth outcomes.  Blue Cross of California, in a 
partnership with local pharmacies, succeeded in increasing HEDIS rates for the appropriate 
use of asthma controller medication from 68.6% to 84.6% for its target population of African 
Americans; those rates also improved similarly for Hispanics and whites.  The health plan 
accomplished this by providing point-of-service prompting and reimbursement to 
pharmacists for asthma consultation through a computerized pharmacy data entry and claim 
system.  These interventions were not culturally tailored, but did provide elements of 
personalization and face-to-face consultation.48 
Finally, the toolkit provided a series of case studies describing different approaches 
for reducing health disparities in birth outcomes and immunizations, asthma care and 
diabetes care.  Three case studies addressed methods to improve diabetes care among 
racial and ethnic minorities, using process measures such as screening rates to measure 
their effectiveness.  In the first case study, SoonerCare Choice, Oklahoma’s primary care 
case management program, educated Native American members with diabetes and their 
providers about plan benefits related to diabetes and the importance of screenings and 
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diabetes management.  Outreach occurred through letters, one-on-one outreach and on-site 
clinic visits.  Nurses followed up with members who missed screenings to reschedule 
appointments and to arrange transportation; the plan also alerted providers about members 
in need of screening.  Finally, SoonerCare Choice evaluated practices at four high-
performing sites, and used the information gained in those evaluations to develop 
educational sessions for low-performing sites.  As a result, HbA1c screening rates rose from 
20.2% to 28.9%, LDL-C screening rates rose from 16.5% to 17.9%, and eye exam 
screening rates rose from 2.1% to 17.7%.38 
In the second case study, HealthFirst of New York identified African American and 
Hispanic members with diabetes who had had no HbA1c testing, eye exam, LDL screening 
or monitoring of nephropathy.   The health plan used a multi-factorial approach that included 
mail and telephonic outreach; member and provider education using registered nurses, 
quality improvement coordinators, and culturally appropriate provider representatives; a $50 
member incentive to complete HEDIS monitoring services; and the use of an electronic, 
interactive machine that reminds high-risk members to perform self-monitoring.  From 2004 
to 2006, HealthFirst had reached 61% of its target population (3,995 members), and saw 
HbA1c testing rates rise from 60% to 79%, eye exam rates rise from 21% to 57%, LDL-C 
screening rates rise from 55% to 91%, and nephropathy monitoring rates rise from 30% to 
52% in its target population.38 
In the third case study, three health plans that represent almost half of the enrollees 
in the Oregon Health Plan used a variety of outreach methods to improve HEDIS diabetes 
screening rates among both high- and low-risk Hispanic members.h Outreach methods 
included diabetes education and screening reminders via telephone and mail, and reports to 
primary care physicians indicating which Hispanic patients had not had the recommended 
                                               
h High-risk members were those who had received no HbA1c tests in the preceding twelve months.  Low-risk 
members had undergone all recommended preventive tests in the previous twelve months. 
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tests in the previous twelve months.  While each of the strategies yielded slightly different 
results, the two health plans using telephone and mail reminders saw HbA1c screening 
rates increase by 80% and 30%.  LDL-C screening rates among Hispanic members in the 
same two health plan populations also improved by 60% and 30%, respectively. The third 
plan, which used reports to primary care physicians, saw no increase in HbA1c screening 
rates and a slight decrease in LDL-C screening rates for Hispanic members.38   
A summary of the diabetes interventions employed by the NHPC and the Improving 
Health Care Quality for Racially and Ethnically Diverse Populations Workgroup, and their 
results, is provided in Table 5. 
Press releases, trade articles and information gleaned from health insurer websites 
reveal that, in addition to the collaborative efforts and case studies discussed earlier, several 
health insurance plans are actively addressing health disparities through a variety of 
mechanisms. In many cases, these efforts are linked to an organization’s diversity initiatives 
and a growing recognition of the changing demographics and needs of the health plan’s 
workforce and membership.  In several instances, these activities highlight health plans’ 
increasing focus on Hispanic populations.49, 50  
For example, Blue Cross Blue Shield of Florida has several disparities-related 
initiatives, including the collection of race and ethnicity data directly from members (on a 
voluntary basis), bilingual (Spanish and English-speaking) case managers, a multilingual 
contact center and a series of Spanish language online tools.  These tools include a medical 
library, hospital quality tools, outcomes and safety standards, a health care cost estimator, a 
provider directory, and member services. In addition, BCBSFL uses Quality Interactions, an 
online cultural competence program for network physicians to role-play with patients from 
different ethnic backgrounds.  This training is voluntary for network physicians and required 
for all clinical staff, such as medical directors, case managers and health coaches.  The  
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Table 5:  Summary of Interventions Employed by the NHPC and the IHCQREDP 
Workgroup to Reduce Racial and Ethnic Health Disparities in Diabetes (With Results) 
Payer-Member Intervention(s) Population(s) and 
Coverage Type
Result(s)
Culturally tailored outreach, using 
bilingual nurses and materials that 
reflect Hispanic cultural norms 
(Molina Healthcare, p. 37)
Hispanics with 
commercial health 
insurance
Positive 
- Diabetes quality measures have improved 
- Members improved in their diabetes 
management self-confidence 
- Coincident decrease in program level of care 
requirements
Education and screening reminders 
via phone and mail to high- and low-
risk members (CareOregon, p. 42) 
Hispanics with 
Medicaid 
Positive 
- HbA1c screening rates increased by 80% for 
one health plan and 30% for another 
- LDL-C screening rates improve by 60% and 
30% for one health plan and 30% for another 
Payer-Provider Intervention(s) Population(s) and 
Coverage Type
Result(s)
Reports to primary care physicians 
on non-adherent members  
(CareOregon, p. 43) 
Hispanics with 
Medicaid 
Neutral to Negative 
- No increase in HbA1c screening rates 
- Slight decrease in LDL-C screening rates  
Payer-Community Interventions Population(s) and 
Coverage Type
Result(s)
Free retinal screening events in 
Hispanic communities with low 
screening rates (Harvard Pilgrim 
Health Care, p. 37)
Hispanics in 
targeted service 
area, regardless of 
coverage 
Mixed 
- 2.5% of plan members invited attended 
- 20% of event attendees were plan members 
- 31% of plan members receiving mailing 
obtained an eye exam (compared to 26.5% of 
those in the control group)
Provider-Member Intervention(s) Population(s) and 
Coverage Type
Result(s)
Physicians in practices with higher 
than average disparities in diabetic 
care sent screening reminders to 
patients (Highmark, p. 37) 
African Americans 
and Hispanics with 
commercial health 
insurance 
Positive 
- Physicians report anecdotally that targeted 
patients are getting screenings (no metrics 
reported) 
Multi-Factorial Intervention(s) Population(s) and 
Coverage Type
Result(s)
Intensified mailing outreach to more 
than 500 African-American and 
Hispanic members and their 
physicians, developed a cultural 
sensitivity program module for all DM 
staff, and implemented a nursing 
education program (Aetna, p. 36)
African Americans 
and Hispanics with 
commercial health 
insurance 

Positive 
- 38% of non-adherent members to obtain both 
HbA1c and LDL-C screenings 
- Intervention group had better HbA1c control 
than those in the comparison group
Mail and telephonic outreach to non-
adherent AA and Hispanic Medicaid 
members; member and provider 
education; monetary incentive for 
members; use of Health Buddy, an 
interactive, electronic self-monitoring 
device (or enrollment in mailing 
reminder program) 
(HealthFirst, p. 42) 
African Americans 
and Hispanics with 
commercial health 
insurance 
 
Positive 
- Reached 61% of its target population 
- HbA1c testing rates rose from 60% to 79% 
- Eye exam rates rose from 21% to 57% 
- LDL-C screening rates rose from 55% to 91% 
- Nephropathy monitoring rates rose from 30% 
to 52%  
Member and provider outreach and 
education; provider alerts for non-
adherent members; “best practices” 
training at low-performing sites 
(SoonerCare Choice, p. 41) 
Native Americans 
with Medicaid 
primary care case 
management 
Positive 
- HbA1c screening rates rose from 20.2% to 
28.9% 
- LDL-C screening rates rose from 16.5% to 
17.9% 
- Eye exam screening rates rose from 2.1% to 
17.7 
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health plan also has a program, For Florida's Health, which allows Floridians who are 
underserved or are without health insurance to find low- or no-cost health care resources in 
all 67 counties; the program’s website is bilingual.  Finally, BCBSFL sponsors a multicultural 
diabetes education program, which provides information about diabetes and more 
importantly, how to prevent or delay the disease. Members can access diabetes information 
in English and Spanish by going to the health plan’s home page and searching for 
“diabetes.” Online information includes the warning signs of diabetes and identifies diabetes 
coverage benefits for members. The program also has an interactive diabetes risk 
assessment calculator so visitors can determine their risk of developing diabetes. These 
tools help patients engage their physicians earlier to develop a plan that can reduce their 
risk of developing the disease.51, 52 
Highmark, Inc., the Blue Cross and Blue Shield plan covering western Pennsylvania, 
has formed a multi-dimensional approach to focus on health care disparities, and has been 
addressing this issue for more than five years.  Cultural competency training has been 
completed by all medical directors and more than 1,000 clinical staff and customer service 
representatives, and nearly all of Highmark's 19,000 employees receive diversity and 
inclusion training on an ongoing basis.   The plan is working with its members to obtain self-
identified race, ethnicity and language preference data through voluntary, confidential 
questionnaires and interactive voice recognition (IVR) telephone outreach, and has thus far 
received a 30 percent response rate from members.  Through Blues On Call, Highmark 
addresses health disparities with customized outreach materials, in which individual 
members receive direct mail with targeted messages based on clinical needs and socio-
demographic variables, such as age, geographic location, socio-economic status, literacy, 
and race/ethnicity.  Highmark has also been engaging practicing physicians through 
newsletters, focused discussion groups, quality management physician subcommittees and 
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targeted educational interventions; in addition, an external advisory panel was created in 
2007 that includes physicians and local and national experts to provide guidance and 
recommendations to improve quality health care and reduce racial and ethic health 
disparities.53  
In addition, many health insurers have established separate, private, not-for-profit 
charitable institutions known as foundations.  These philanthropic entities allow health 
insurers, through grant-making and policy initiatives, to extend their influence beyond the 
traditional reach of the health care system.  In 2005, Blue Cross and Blue Shield of 
Massachusetts awarded $3 million in grant funds to reduce racial and ethnic health care 
disparities.  These funds went to the Caring Health Center, Inc., to support program to  
reduce diabetes-related health disparities affecting African American and Hispanic residents 
in the greater Springfield area by addressing patient, provider, and system-level issues.  The 
other recipient, Cape Cod Free Clinic and Community Health Center, proposed to develop a 
continuum of services to identify and coordinate care for African American, Latin American, 
and Native American residents that have untreated and poorly controlled diabetes.54 
CareFirst, the Blue Cross and Blue Shield health plan covering northern Virginia, the 
District of Columbia and Maryland, is addressing health disparities among specific racial and 
ethnic groups through their CareFirst Commitment initiative.  As part of this program, 
CareFirst has partnered with Baltimore Medical System (BMS) to improve care for African-
Americans and Latinos who suffer from chronic illnesses such as diabetes and heart 
disease through innovative home intervention by promotoras – community health workers – 
and the introduction of electronic health records and education enhancements to better 
manage patient care.  In addition, CareFirst Commitment contributed to La Clínica Del 
Pueblo, a D.C.-based clinic serving a mostly Latino clientele, in its unique diabetes 
management program. La Clínica has recruited 175 patients into a program to provide 
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comprehensive diabetic education and care, including in-home education for some patients 
to deliver care in a culturally sensitive way to patients who often forego care.55-58  
A number of studies, papers and reports from researchers, agencies and health 
insurers strongly reinforced the need for the collection of race, ethnicity and language 
preference data to address health disparities, despite its many challenges.38-40, 43, 44, 46, 48-50, 53, 
59-64  Plans must have these data in order to identify differences in health status and 
utilization, and to develop, implement and monitor intervention programs aimed at reducing 
and eliminating gaps in care.  Such data can also help plans set priorities, design programs, 
better understand the health needs of specific populations, evaluate performance 
differences among and within plans, geographic areas, physician groups, etc., and provide 
the foundation for rewarding good performance.38, 43, 46, 48, 62-64 
How effective are current interventions in the health care system at addressing racial 
and ethnic gaps in care and outcomes?  Peek et al., in a systematic review of health care 
interventions to reduce health disparities in diabetes, found good evidence for the ability of 
current health care interventions to enhance diabetes care, improve diabetes health 
outcomes and potentially reduce health disparities among racial/ethnic minorities, including 
Latinos.65  
While the study found no single optimal target for interventions, each type of 
intervention (patient, provider, and health care organization) brought about improvements in 
care and outcomes -- and provided specific lessons learned.  At the patient level, 
interpersonal interventions using nurses, nutritionists or health educators were more 
successful than computer-based interventions.  Culturally tailored interventions were much 
more effective among racial/ethnic minorities, while the effects of generalized diabetes self-
management interventions were modest.  This is not surprising, given that culturally tailored 
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interventions deal specifically with the barriers to health care that minorities face, such as 
language, cultural norms, and socioeconomic status.    
Culturally tailored patient interventions provided positive impacts on health 
knowledge, behaviors and outcomes, although they varied in which health outcomes were 
affected.  Examples of successful culturally tailored interventions include the provision of 
educational materials in the patient’s language and at the appropriate literacy levels; dietary 
recommendations that consider cultural preferences for certain types of foods and access to 
substitutes; and physical activity recommendations that incorporate cultural norms about 
exercise and accommodate access to venues for such activities.  This finding is supported 
by the multiple observational studies have found that culture, socioeconomic status, and 
social support, self-efficacy, and coping skills play a large role in explaining diabetes self-
case and health outcomes.66, 67   
At the provider level, in-person performance feedback to physicians was superior to 
computerized decision support in effecting sustained provider behavioral change and health 
outcomes.   In one study, feedback consisted of face-to-face, one-to-one sessions between 
an endocrinologist and the physician providing care.  These sessions, occurring every two 
weeks and lasting five minutes apiece, consisted of a review of individual provider actions or 
outcomes specific to the patients seen by that provider.  Emphasis was placed on achieving 
American Diabetes Association goals and on acting appropriately when values such as 
blood sugar levels were abnormal during patient visits.68  Evidence also suggests that 
targeting providers and facilities that serve racial/ethnic minorities for interventions may be 
highly effective in reducing health disparities.65 
For health care organizations, the authors found that the use of case managers, 
community health workers, and nurses acting as clinicians (via treatment algorithms and 
physician support) positively affected both the processes and outcomes of care for racial 

 
 
 
 49
and ethnic minorities with diabetes.  In particular, the use of nurse case managers improved 
both the quality of care and outcomes, including diabetes control and the onset of 
retinopathy.  Community health workers (CHWs), given their effectiveness in acting as a 
patient adjunct to the primary care team and making and keeping patient appointments, may 
make case management a financially viable option for health centers with limited 
resources.69  The study also found evidence that case management is particularly important 
in medically underserved populations because it addresses common barriers to adherence 
through patient education, identification of ancillary services (such as home health), 
providing ancillary services (such as testing and vaccinations), and overcoming logistical 
issues (such as transportation).70   
In a related examination of the efficacy of generalized pharmacy-related health care 
organization interventions, Peek et al. found two studies of pharmacist-led medication 
management and patient education; both reported improvements in HbA1c levels. 71, 72  One 
study examined a clinic-based medication assistance program, in which uninsured 
individuals and Medicare enrollees received 2-3 month increments of pharmaceutical 
company-sponsored medication.  The program improved medication adherence and 
resulted in clinical improvements in HbA1c, LDL and triglyceride levels.73  
Finally, in a finding echoing that of this study’s literature review, Peek et al. found 
mixed results for the efficacy of disease management programs at improving diabetes 
outcomes.  One study that included a diabetes registry, case management and visit 
reminders found positive impacts on both diabetes control and process measures for African 
American women in a rural setting.74, 75  Another study, a systematic review of effectiveness 
of disease management among patients with diabetes, reported better diabetes control and 
increased screening rates for neuropathy, dyslipidemia, and microalbuminuria.76 In this 
case, disease management was defined as the identification of the population with diabetes; 
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guidelines or performance standards for care; management of identified people; and 
information systems for monitoring and tracking.  A more recent study of 63 physician 
groups in 11 care, found improvements in processes of care, but not with improvements in 
health outcomes. In this study, disease management was defined as physician reminders, 
performance feedback, and structured care (the use of formal case management, diabetes 
guidelines, patient reminders and patient education).  The authors concluded that more 
focus on direct measurement, feedback and reporting on intermediate outcomes (such as 
HbA1c, systolic blood pressure and LDL-C levels) is required.77-79  
Several additional studies found that the provision of culturally and linguistically 
competent care has the potential to improve health care access, quality and outcomes, and 
reduce disparities in care.33, 39, 65  Cultural competence is a term used to describe “a set of 
congruent behaviors, attitudes and policies that come together in a system, agency or 
amongst professionals and enables that system, agency or those professionals to work 
effectively in cross-cultural situations.”80  Fisher et al. note that while this term often refers to 
the ability of clinicians to interact successfully with patients whose backgrounds differ from 
the mainstream culture, the term is also used to describe how health care systems interact 
with patients.34  
Understanding and integrating cultural components, particularly for Latinos, is critical 
for success in closing gaps in quality of care.34, 48, 56, 81, 82  In addition, Fisher et al. found that, 
while cultural competence is an important part of the solution to reducing health disparities, 
culturally leveraged nursing and community health worker interventions improved processes 
of care and outcomes. The authors define cultural leverage as “a focused strategy for 
improving the health of racial and ethnic communities by using their cultural practices, 
products, philosophies, or environments as vehicles that facilitate behavioral change of 
patients and practitioners.”34  Other promising methods include the use of promotoras or 
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multicultural community health workers, peer support, family inclusion, community 
engagement, and participatory learning that considers low literacy levels for Latinos, as 
described below. 34, 48, 56, 81, 82  
Chin, et al. reviewed six papers examining the impacts of interventions using cultural 
leverage on cardiovascular disease, diabetes, depression, and breast cancer, and found 
that multi-factorial, culturally tailored interventions that target different causes of disparities 
(social norms, the patient environment, and the health care environment) seem to hold the 
most promise for reducing health disparities.33  The authors argue that the success of 
culturally tailored quality improvements may be a result of their ability to provide a 
mechanism of individualizing care for ethnic minorities.   For diabetes in particular, some of 
the most powerful interventions targeted patient, provider, organization, and community 
factors simultaneously, often employing multidisciplinary teams, patient registries and a 
variety of intervention techniques (patient education, nurse case management, treatment 
algorithms, community outreach with community health workers, patient incentives, 
continuous quality improvement, and group visits).  Peek et al. (cited earlier) also found 
evidence that culturally tailored programs with enhanced community involvement may be an 
important factor in the success of multi-target interventions at improving diabetes health 
outcomes.65 
The study also asserts that despite a lack of evidence in the studies examined, there 
are theoretical and practical reasons to believe that cultural tailoring may enhance the 
effectiveness of general quality improvement interventions among ethnic minority groups.  
Examples of this include the Advancing Diabetes Self-Management (ADSM) project at La 
Clinica De La Raza in Oakland, which uses a multifaceted approach to improve diabetes 
self-management for Spanish-speaking adults with type 2 diabetes.  The program employs a 
theoretical model of behavior change, and incorporates peer support, bicultural community 
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health coaches (promotoras) and patient-centered counseling.83  Other successfuli 
examples of multi-factorial approaches to improving diabetes self-management for 
Hispanics include the Diabetes Health Disparities Collaborative, the Campesinos Sin 
Fronteras initiative, and the Open Door Health Center’s Prescription for Health Diabetes 
Project.81, 82, 84  These findings are supported by the Peek et al. study; while the authors 
found that there were few head-to-head comparisons between culturally tailored and generic 
quality improvement programs, the study’s meta-analysis found that culturally tailored 
patient interventions resulted in a larger reduction in HbA1c values than general quality 
improvement interventions did.65 
The National Quality Forum, in its August 2008 issue brief on closing the disparities 
gap, reiterates the need for evidence-based, targeted, culturally tailored interventions – 
based on early successes of such techniques.48, 60, 85, 86  The report also outlines a series of 
analytic steps to target improvements in diabetes care for Hispanics.48  
The Decreasing Disparities Strategy Workgroup of the Agency for Healthcare 
Research and Quality (AHRQ), whose aim is to reduce disparities in quality and/or access to 
care in priority populations through establishing improved methods of transferring 
knowledge from researchers to providers, purchasers, and policymakers, embarked on a 
learning network project to reduce the diabetes disparity in the Hispanic population. The 
Workgroup targeted community health centers with a predominately Hispanic population for 
this intervention, which was conducted from June 2006 to January 2007.   
The project demonstrated that clinics can make significant progress in their patient 
goal-setting performance, even when patients participate in short learning sessions (4 
hours) over an abbreviated period of time (6 months).   The workgroup also learned that the 
likelihood of success is greater if interventions are culturally tailored, and produced a list of 
                                               
i Results are asserted but not specifically reported. 
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Lessons Learned to Improve the Care of Hispanic Persons with Diabetes, summarized as 
follows:    
 
1. Any written materials for Hispanics in community health clinics should be developed 
for a low literacy level; many may be illiterate and not volunteer this information. 
Simple pictures on materials and tools have helped to increase interest and 
understanding. 
2. Materials validated in Spanish may still be inappropriate for the clinic population if the 
concepts embedded are not familiar to the culture of the population being served.  
During this intervention clinics did not identify specific variances in the cultures of 
persons from Mexico or Central America that require a different approach in designing 
services. 
3. Hispanics are generally family oriented, and this is important for motivating them for 
lifestyle changes and compliance to a care plan. Parents may be motivated to take 
better care of themselves in order to better care for their children. 
4. Family members, preferably living with the patient, should be invited and encouraged 
to participate in classes for persons with diabetes. If the patient is male and there is a 
female in the home that prepares food, it is crucial to have this person present during 
classes and maybe clinic visits. 
5. Food is very important in this culture, and mothers may use it as a reward within 
families. Recognize the importance of food and seek healthier ways to prepare food. 
Often Hispanics are open to trying other ethnic foods that can provide variety and still 
be healthier. 
6. Many exercise options are not accessible or acceptable to Hispanics. Walking, biking, 
and dancing are common options used. Even walking can be hazardous in some 
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urban settings and suburban settings without sidewalks; very few localities have 
central plazas, a common feature in Latin American communities.  Work with the 
patients in interactive goal setting to see what is feasible for individuals. 
7. Hispanics often take the medical advice of a well-respected person in the community 
over that of the clinician in the clinic. Unfortunately, they usually do not discuss any 
differences of opinions with the clinician because he or she is an authority figure. For 
this reason it is even more critical for interactive goal setting with Hispanic patients to 
elicit what is important to the patient and what changes the patient is ready to make. 
8. Latinos will keep appointments and attend classes better if the environment feels a 
part of their culture and they are comfortable in it. Facilities that are old and crowded 
can be more successful than facilities that are more spacious and clinical in 
appearance if patients and their families feel comfortable and welcomed by people 
they trust. 
9. A myth exists in this culture that insulin can actually worsen the symptoms and 
complications of diabetes. The clinician must address why this myth exists (i.e., 
patients waited too long to start insulin and the damaging effects were already 
present) and why waiting can increase the complications of diabetes. However, 
clinicians should never intimate that patients who maintain good control will never 
have to use insulin. This can cause a trust problem since even patients with good 
control might eventually have to use insulin. 
10. When translating materials or discussing mental health issues with Hispanics, avoid 
using the term "depression." The term evokes a more negative response in this 
culture, and patients will deny having symptoms. Instead ask, "Do you feel sad more 
often; do you have trouble finding energy to do the things you usually do?”84 
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What about the ability of provider pay-for-performance to reduce racial and ethnic 
health disparities?  In an interesting examination of the effectiveness of such programs in 
closing care gaps, Chien et al., finding only one empirical study examining the question, 
interviewed the leaders of fifteen pay-for-performance programs.  The authors found that 
current pay-for-performance programs are not designed to reduce disparities and often lack 
characteristics that may be important in reducing disparities.  The study recommends that 
health plans, in order to address these shortages, collect race and ethnicity data, emphasize 
conditions of higher prevalence in minorities to providers, reward improvement for reducing 
health disparities, and encourage nationally prominent organizations to establish disparity 
guidelines or measures.32  The NQF, in its 2008 briefing on reducing gaps in care (cited 
earlier), also calls for such guidelines or measures.48 
Despite the promising research and the increasing levels of activity aimed at 
reducing racial and ethnic disparities, questions about what types and combinations of 
interventions are most valuable and most cost-effective -- as well as how cultural 
competence and cultural leverage should be integrated into generic quality improvement 
initiatives to be most effective – continue to plague both researchers and health care system 
stakeholders.31, 34  This presents a real challenge for both health care organizations and 
health plan purchasers, who often must know (or at least project with some certainly) 
whether the investment in a given intervention will produce the desired outcome, in order to 
secure and maintain funding and other organizational support for the intervention(s).   Lurie 
et al. point out that valid assessment of the true financial impact of any intervention 
necessitates strong evaluation design, which will in turn require access to data that is often 
costly and sometimes difficult to obtain (for example, member race/ethnicity, programming 
costs, and utilization patterns over time).  Such designs are also better suited for 
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interventions and outcomes that are measurable in a relatively short period of time, which is 
typically not the case for a chronic disease such as diabetes.33, 41, 87  
In an effort to facilitate the development and use of ROI analysis for health plans and 
other organizations requiring a business case to secure funding and support for health 
disparities programs, three members of the National Health Plan Collaborative piloted and 
refined several ROI analysis tools.  These tools, which use both prospective and 
retrospective techniques for forecasting and program evaluation, are now published on the 
CHCS website.88  The forecasting calculator also includes an “evidence base” dataset, 
which allows users to populate forecast assumptions with data from comparable initiatives 
and published studies.  Clinical topics include asthma, congestive heart failure, depression, 
diabetes and high-risk pregnancy. 
Health insurers and employers face additional challenges in the quest to produce a 
business case for interventions.  First, any returns might not be realized for quite some time 
after the investment is made (a problem particularly applicable to a long-term, chronic 
disease such as diabetes), and second, given that potential delay in ROI, compounded by 
the fact that many members, patients and employees switch health insurance carriers, 
physicians and employers over time, any returns may accrue to other parties (for example, 
other  -- and sometimes, competing -- health insurers, physician practices or employers) 
who made no investment in the intervention.41, 87    
Thus, the business case for interventions to improve care quality and reduce health 
disparities is as yet unclear, and will likely remain so for the foreseeable future, given the 
complexities and costs of designing and implementing valid intervention assessments that 
successfully address the issues outlined above.  The business case for addressing racial 
and ethnic health disparities in diabetes is particularly difficult, given the long course of the 
disease, its multiple drivers, and the fact that most studies have only examined 
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improvements over a 1-2 year period – likely too short an evaluation period to definitively 
determine the long-term impact and sustainability of those improvements.33, 78   
Despite these challenges, many observers -- noting the hundreds of articles and 
papers written, presentations made, and studies conducted on racial and ethnic health 
disparities -- are suggesting that it is time to move beyond simply documenting the problem 
and turn our efforts toward taking actionable steps to eliminate health disparities.39, 49  
Specifically, Lurie et al. assert that health care organizations, in the absence of an airtight, 
quantitative business case, can take targeted steps to reduce disparities in ways that use 
scare resources effectively.  Suggestions include: targeting health care providers that serve 
large numbers of minority patients and that provider lower-quality care; using geographic 
information systems (GIS) tools, along with care quality data, to map by census-tract areas 
of poor quality care; and partnering with other community stakeholders to reduce disparities.  
This latter approach, Lurie suggests, can not only improve the effectiveness and 
sustainability of the program(s) but, by involving more stakeholders, it can lower the costs to 
any one organization.87  
  
CHAPTER 5: KEY INFORMANT INTERVIEW FINDINGS 
 
Descriptive Analysis 
The organizations included in this portion of this study are on the leading edge of 
private payer industry with regard to the movement to reduce racial and ethnic health 
disparities.  This point is important to set a relative context for the findings contained herein:  
These health plans arguably have levels of experience, commitment, organizational 
readiness and maturity that surpass the vast majority of health plans in the United States.    
Why?  Most of the health plans that participated in the key informant interviews have 
been formally addressing disparities for more than four years.  Formally addressing in this 
context means that the health plan has dedicated resources, a working committee or task 
force, specific organizational goals, or any combination thereof related to the reduction or 
elimination of racial and ethnic health disparities.  The majority of the participating 
organizations began their efforts in 2004, shortly after the 2003 publication of the IOM 
report, and in conjunction with the initiation of the NHPC. In addition, each of these health 
plans is participating in one or more industry collaborative efforts with other health plans, so 
they have access to the collective pool of experience and knowledge developed through 
these partnerships. 
One firm, while it is participating in one of the collaborative efforts to reduce racial 
and ethnic health disparities mentioned earlier, is not formally addressing disparities.  
Instead, it is focused on capturing the Hispanic market.   
Our driver has not been addressing health disparities.  Our driver has been to 
capture the Latino market.  Now how we got there, or how we decided to go after the 
Latino market was because we found that the population was truly underserved.  It’s 
not a pure health disparity [issue], but that’s a factor. 
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This case study is included because, although its objectives and approaches differ 
from the other health plans interviewed, this organization’s strategy, methods and 
experiences provide interesting insights into the Hispanic population, from both marketing 
and health education perspectives.  These insights are due in no small part to the fact that 
one of the key informants interviewed at this organization is of Hispanic heritage; this 
individual’s deep understanding of the Hispanic culture served to validate, refute and enrich 
the hypotheses, assumptions and practices of other sources used for this study. 
Multiple factors drove participating health plans to address racial and ethnic health 
disparities in general, but most respondents pointed to the widening and more obvious gaps 
in care that racial and ethnic minorities experience, the recognition that these gaps present 
barriers to improving the overall health of their members, and a growing awareness that 
broad stroke approaches to quality improvement will not adequately address the needs of 
these populations.  Four respondents cited the 2003 IOM report -- and the visibility into the 
role of the health care system and the clinical encounter in health disparities that that report 
provided -- as one of their initial drivers; an equal number noted that addressing health 
disparities is “the right thing to do.” 
An organization cannot commit to a quality improvement agenda without addressing 
disparities. 
 
Health disparities have emerged as a huge organizational priority for us.  We are 
trying to do the right thing for our patients and members.  We have an obligation to 
address health disparities, and we are pursuing that through the development of 
ideal practices and proving outcomes. 
 
There was a very strong commitment that this was the right thing to do, and we 
really want to be responsive to our members’ needs. 
 
It was the 2003 IOM report on equal treatment.  That’s where we began. 
 
Here’s the thing:  With the demographics of our country changing the way they are, 
you have to be engaged on this whole issue. 
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A strong push by senior management, anecdotal data from physicians, and industry 
trends were also mentioned.  Industry trends included two main components:  activity by the 
health plan’s competitors to address health disparities, and growing demand from national 
accounts for evidence that the health plan is actively seeking to reduce health disparities.  
This latter factor is evidenced by the increasingly frequent inclusion of questions from 
potential customers about the plan’s disparities reduction efforts in requests for proposal 
(RFPs), a formal method whereby groups seeking to purchase health insurance evaluate 
candidate health plans.   
It’s a potential marketing advantage.  We know what we look like in the U.S. now, 
and we know what we will be like in the next 5, 10, 15 years [referring to the 
racial/ethnic composition of U.S. population]. 
 
Over the past year, we have seen more and more questions about what we’re doing 
to address health disparities in our larger and national account RFPs.  Our biggest 
customers are starting to demand that we take action. 
 
 
Participation in the NHPC, pressure from workforce diversity initiatives to better 
serve the needs of an increasingly diverse marketplace, and a desire to capture the 
Hispanic market each received more than one mention by respondents.  One respondent 
indicated that the anticipation of future accreditation and regulatory requirements to reduce 
health disparities and improve the cultural competence of health plans had played a role in 
the commencement of that organization’s formal disparities reduction efforts.  Interestingly, 
only one of the interviewees specifically mentioned health care cost savings as an initial 
driver. 
With one exception, the plans’ percentage of Hispanic membership equaled or 
lagged that of the average for the US population (see Figure 6).   Estimates ranged from 
less than 10% to 38%j; however, six of the seven plans with estimates were between 10% 
                                               
j The 38% estimate is for that health plan’s target service area only, not for its total commercial membership. 
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and 15%.  (The US Census Bureau reported that, as of July 1, 2008, 15.1% of the US 
population was of Hispanic/Latino origin.89)   The growing Hispanic population in the United 
States -- and the expanding portion of the total population which it now represents -- make 
addressing health disparities for Hispanics increasingly essential for health plans. 
 
Figure 6:  Hispanic Percentage of Total Membership By Participating Plan 
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Finally, six of the eight health plans included in this study have one or more 
programs targeting Hispanics with diabetes (see Table 6).  These programs may be part of a 
larger effort to reduce health disparities in diabetes among multiple racial/ethnic groups, or 
they may be solely focused on Hispanics.  In a finding echoing that of both the literature and 
document reviews, the vast majority of these programs are still nascent, having been in 
place from less than a year to two years.   
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Table 6:  Hispanic Membership and Program Characteristics By Health Plan 
Payer Hispanic Percentage 
of Total 
Membership* 
 Diabetes 
Program(s) for 
Hispanics 
Duration of 
Program(s) 
(Years) 
Health Plan #1 12 1 1 
Health Plan #2 <10 1 2  
Health Plan #3 15 0 -- 
Health Plan #4 15 2 2 and 5 
Health Plan #5 11 0 -- 
Health Plan #6 10 1 <1 
Health Plan #7 38k 2 <1 and 2 
Health Plan #8 Not known 1 2 
*As provided by key informants. 
 
Key Findings 
Key Finding 1:  Collecting member race/ethnicity data, and establishing institutional 
confidence in it, is critical to both confirm the presence of health disparities within 
the health plan’s member population and to serve as a springboard for organizational 
action.     
All respondents stressed the importance of proving the existence of health disparities 
in the health plan’s member population. For most plans, that involved the collection of race 
and ethnicity data on their member population and performing disparities analysis, usually of 
process measures (e.g., HEDIS).   
I would say that, to get started – and that’s always a big challenge for many 
programs and health plans – just start by doing health disparity analysis with 
whatever data you can get, whether it’s state-sponsored data feeds…if you can get 
even just a portion of the [race/ethnicity] data and be able to demonstrate that 
disparities are a real issue…it becomes more compelling. 
 
For [us], it was showing that our membership had disparities based upon our geo-
coded data, and that helped drive a commitment.  The geo-coded data helped our 
senior leadership say, ‘Okay, let’s collect the direct data.’  So that was a key lever for 
us. 
 
                                               
k The 38% estimate is for that health plan’s target service area only, not for its total commercial membership. 

 
 
 
 63
Participating plans are employing an almost equal mix of direct techniques, 
indirect/imputed techniques, and a combination of both.  As outlined in Chapter 4, indirect 
techniques for the collection of race and ethnicity data include the evaluation of language 
utilization data, geo-coding, and surname analysis (with and without first name analysis), 
Geo-coding uses a member’s residence to approximate the likelihood of a member’s race or 
ethnic background; this technique is used primarily to identify enrollees who are likely to be 
African American.  Surname analysis, typically used to identify Asian and Hispanic 
members, compares a person’s last name to a long list of surnames known to have a high 
probability of belonging to someone from the specified racial or ethnic group.37-39 
Direct data collection techniques include the use of mailed member surveys, paper 
and online enrollment forms, health risk assessments (HRAs), electronic medical records 
(EMRs) and online member services.  Other direct collection techniques utilized by 
respondents include the evaluation of requests for translation and birth data.   Such 
techniques, while widely acknowledged as being more accurate, are also costly and slow.  
Those plans using direct techniques alone reported having race and ethnicity data on 20-
35% of their target population, while plans using indirect techniques reported having data on 
90-100% of their target population. 
One health plan, lacking race/ethnicity data on its members, analyzed its own 
employee population for disparities; the organization found them in prenatal visits, delivery 
complications, and diabetes care and complications between their Hispanic and African 
American employees and their Asian American and Caucasian employees.  This finding 
supports the IOM assertion that health disparities exist even when factors such as access to 
health care and coverage are controlled, and suggest that a health plan’s own population 
may be fertile – and valid – ground for establishing a business case for reducing health 
disparities. 
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It was very shocking to us that this level of health disparity existed among our own 
employees.  I mean, this is a group that shouldn’t have language barriers because 
we all work at [health plan] on a daily basis.  We all have insurance through [health 
plan.] 
 
 
Several respondents mentioned the importance (and difficulty, in some cases) of 
convincing internal stakeholders that health disparities do exist in the plan’s member 
population.  As one respondent put it, “Develop institutional confidence in your data; that can 
be a real distraction and impediment to forward progress.”  Another noted, “There were a 
number of people in senior management that refused to believe that we had a [health 
disparity] problem until we put the data in front of them.  And then we had to convince them 
that the data were valid!” 
 
Key Finding 2:  The relative nascence of programs aimed at reducing disparities in 
Hispanics with diabetes, combined with the absence of stakeholder incentives and 
the sole and predominant usage of member interventions, suggest that most 
organizations are adopting a cautious approach to this problem.   
 Table 7 summarizes the types of interventions used, whether stakeholder incentives 
are included, and the number of years the program(s) have been in place for those 
programs aimed at reducing disparities in Hispanics with diabetes.  A total of six of the 
participating health plans have one or more programs to reduce diabetes among Hispanics 
currently in operation.  These health plans are predominantly using payer-member 
interventions; in fact, most of the programs in operation employ them exclusively.   The 
study found only one instance each of the use of payer, community and multi-factorial 
interventions. 
In a direct extension of general quality improvement programs, the most commonly 
used payer-member intervention is a culturally tailored diabetes screening reminder,  
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provided through mail and automated outbound telephone calls.  Culturally tailored for most 
of the health plans means that the recordings used in telephone calls and the mailed 
materials are translated into Spanish.  Two of the telephonic methods included interactive 
voice response (IVR) technology, which invites call recipients to request more information on 
diabetes from the insurer.  This allows the health plan to capture important information about 
the respondent, such as a validated name, phone number, address, race/ethnicity category, 
and an indication that future interventions may be successful with this individual.   
 
Table 7:  Summary Characteristics of Disparities Reduction Programs for Hispanics 
with Diabetes Implemented by Participating Health Plans 
Payer Point(s) of Intervention Stakeholder 
Incentives 
Providedl 
Duration of 
Program 
(Years) 
Health Plan #1 Payer-Member No 1 
Health Plan #2 Payer-Member No 2 
Health Plan #4 Multi-Factorial No 5 
Payer-Community No 2 
Health Plan #6 Payer-Member No <1 
Health Plan #7 Payer-Provider No 2 
Payer-Member No <1 
Health Plan #8 Payer-Member No 2 
 
One of the six plans has a disparities reduction initiative that includes Hispanics with 
diabetes and incorporates a payer-provider intervention, described by the respondent as 
follows:  
For the providers…we take the health disparity profiles that we developed for a 
particular region and, depending on the local quality department’s request, we might 
identify a few medical groups and their primary care physician office and we will map 
it out.  For physician offices that fall into very heavily disparate zones, the quality 
improvement department might reach out to that particular medical group and just 
say that they seem to be practicing in a very health disparities heavy location and 
when we look at your member mix, it looks like there are health disparity 
patterns…Is this what you’ve observed?  What do you think are the drivers that 
cause this?  What can we do to help you? 
                                               
l Refers only to whether incentives specific to the program are in place.  Several organizations have overall 
health disparity reduction incentives (e.g., for employees and providers), which may contribute indirectly to the 
performance of these programs. 
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For this plan, a contracted delivery system, there is currently no requirement or incentive for 
the provider to act upon this information. 
Only one plan interviewed reported a community-level intervention targeted 
specifically at Hispanics with diabetes.  Through a community health collaborative focused 
on health care access for Hispanics, this health plan is using subcontracted health behavior 
and health education resources to improve diabetes self-management in a catchment 
population with non-optimal blood sugar control.  The program has been place for three 
years now, and has achieved optimal glycemic control among more than 200 program 
participants to date.  
Despite the fact that multiple sources in the document review extolled the promise 
and efficacy of multi-factorial interventions, only one health plan has a program aimed at 
reducing health disparities in Hispanics with diabetes that involves multiple stakeholders.  In 
this case, the same health plan that is employing the community-level intervention just 
described (and one of the two integrated delivery systems included in this study), is using a 
disease/patient registry and a provider-initiated treatment protocol (a drug regimen) to 
reduce the risk of cardiovascular mortality among its Hispanic members with diabetes. Case 
managers and community health workers also follow up with members to increase their 
compliance with the program.  According to the plan’s medical director, the essential 
components for the success of this program were:  bilingual, bicultural outreach to members; 
an engaged multidisciplinary team (physicians, nurses, pharmacists, case managers and 
community health workers); coordinated care delivery that involves the laboratory (for testing 
and results) and the pharmacy (for patient education and prescription activity data); and a 
disease/patient registry. 
As outlined earlier, many health insurers have established separate, private, not-for-
profit charitable institutions known as foundations.  These philanthropic entities allow health 
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insurers, through grant-making and policy initiatives, to extend their influence beyond the 
traditional reach of the health care system.  Several respondents indicated that their 
foundations were funding grant requests for community-level health disparity reduction 
programs, and two respondents indicated that their foundations had specific grant focus 
areas around reducing disparities.  In general, however, these efforts were not coordinated 
with other disparity initiatives. 
Neither member nor provider incentives are commonly used in programs aimed at 
Hispanics with diabetes.    To illustrate, none of the health plans interviewed have changed 
benefit plan designs to induce members to change their care-seeking behavior.   Examples 
might include lowering or waiving co-payments for screening visits or test supplies.   (There 
is one indirect exception to this – the health plan that evaluated disparities in prenatal and 
diabetes care among its employee population to produce its business case.  In that 
instance, the health plan waived prenatal visit co-pays as a standard benefit.) 
All of the plans interviewed have considered provider pay-for-performance 
mechanisms for closing racial/ethnic gaps in care.  None of them have yet implemented 
them  – and they were at notably differing levels of readiness to do so.   
The challenge for [us], and here’s the main reason why we won’t be including it [in 
pay-for-performance programs] any time soon, is that we don’t have the member 
self-reported data.  It’s never that compelling when you’re using estimated data.  It’s 
a lot more suspect…I don’t know how we can ever make it a true pay-for-
performance when, one, you don’t have the data on everybody, and two, if you do 
through indirect methods, it’s an estimate.  The physicians are not going to buy it.  
That’s not to say that as the industry changes because it is more of a high priority 
topic that people won’t try to make it pay-for-performance. 
 
It’s pretty high level, but we have brought that up, that we may at some point like to 
look at that. 
 
As part of our pay-for-performance program for our primary care physicians, we’ll be 
measuring disparity-related process indicators, beginning in 2009. 
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One integrated delivery system does provide an optional performance bonus for contracted 
providers who collect race/ethnicity data.  This is included as a process measure component 
of their pay-for-performance program.    
Organizations are more likely to use employee incentives than they are provider 
incentives – at least from an overall health disparities reduction standpoint.  For example, 
one of the integrated delivery systems interviewed bases a portion of provider compensation 
on a proprietary overall member health index.  Another health plan is actually including an 
overall member health index (not specific to Hispanics with diabetes) as part of every 
employee’s incentive compensation plan.  
I mention the member health index that is not just HEDIS [measures] but includes a 
lot of other administrative data-related metrics as well.  The member health index to 
those of us at [health plan] is an indication of how healthy our [member] population 
is…These numbers are actually a part of all [health plan] associates’ performance 
incentive… It may not be hugem.  It can range anywhere from 5 to 10% [of the 
incentive compensation package] given the years’ priorities, but some portion of it is 
always tied to the overall improvement of these scores.  Even if there isn’t a distinct 
monetary ROI in the reduction in the medical cost of care, just the fact that if we’re 
able to move the needle on improving these measures, that’s a goal that everyone in 
the company would be pleased to reach as well. 
 
Both respondents indicated that, while these incentives are not directly aimed at 
reducing racial and ethnic health disparities, there is likely an indirect effect, given that the 
rising health improvement tide must float all boats – regardless of race or ethnicity -- in order 
for the health plan to meet its goals. 
 These findings illustrate that, at least for now, addressing health disparities is risky 
business -- particularly for chronic and complex diseases like diabetes.  The cultural barriers 
that Hispanic populations face in the health care system provide additional and substantial 
hurdles for health plans to cross.  While the document review uncovered promising hints of 
the efficacy of cultural targeting at reducing disparities among Hispanics, that evidence base 
                                               
m Associates are employees of the health plan. 
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is still small.   Thus, extending existing disease management programs (which primarily 
employ member interventions), avoiding the use of costly (and unproven) member 
incentives and potentially contentious provider incentives represent a rational approach in 
the face of such uncertainty.    
 
Key Finding 3:  Health plans are beginning to realize the necessity of understanding 
the specific characteristics and needs of their target Hispanic population(s) to design 
effective interventions.  They also recognize the risks of assuming that Hispanic 
populations will respond to literal translations and to the same messages and 
communication vehicles as non-Hispanic populations. 
[Health plans] need to go out in the communities and determine what the community 
needs are, and they need to be respondent [sic] and focused on meeting the needs 
of their community.  To me, that’s a very simple script. 
 
[Health plans] really need to do their homework and understand the population that 
they’re trying to serve; [they need to] really understand what the population is and 
what the problems are that are in that community.   
 
 
There are important differences between sub-segments of the Hispanic population.  
Such differences include -- among other things -- socioeconomic status, language isolation, 
and country of origin.  This latter variable drives significant cultural differences between 
Hispanic groups -- from language to cultural norms and values – that are critical to 
understand in order to effectively reach these populations.  As one respondent put it, 
“Determination and pursuit of the required granularity associated with the data is critical to 
designing the most appropriate interventions.” 
It’s really important that the messaging is not just in Spanish, but in the right 
Spanish.  All Latinos are not the same…so our communications style has to be a 
generic, safe, [we have to] get away from all of the colloquial words and just make it 
very professional, safe, easy to understand communication.  That’s very important. 
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In addition, communication and outreach methods developed for and by persons of 
non-Hispanic heritage are not always effective with Hispanics, underscoring the need to 
acquire specialized skills to develop those methods. 
We did a lot of talking with the [Latino] community and realized that our traditional 
methods of even marketing or educating would not work in the Latino community.   
 
I think that a lot of times we assume a number of things with our own cultural filters 
[such] that we are not really developing things that truly reflect the population. 
 
It’s really important that the imagery is right.  Latinos are all about family, not about 
anything else.  So that’s what needs to be reflected. 
 
We found that it is very effective to hire vendors who specialize in [Hispanic] markets 
to come up with the materials because they live and breathe the requests or the 
needs of those communities day in and day out. 
 
…our market research department is uniformly Caucasian.  If you’re going to be 
interviewing…Latinos, you really want a facilitator who is reflective and who is 
bilingual in the case of the Latino population.  Our vendor is able to do that, and our 
internal department is not. 
 
 
Two respondents specifically mentioned that their organizations had successfully 
used novelas in both health education and marketing aimed at Hispanics.   Novelas, which 
use the art of story-telling (in photo or video form) to get messages across to readers or 
viewers, are being used increasingly by marketers and health educators to more effectively 
reach the Hispanic market.90, 91 
[The novela] is the exact mechanism that we chose to educate employees during an 
open enrollment meeting where a plan is being offered as an option for them to sign 
up.  We created three mini-novelas…that talk about the benefits of health care… 
When we show the DVD to a prospective audience where, prior to our doing any 
work we would get 20% of Latinos signing up for health care, after showing the 
video, it jumps to 90 to 100% enrollment. 
 
We realized that they [Hispanic focus group members] were so familiar with this 
medium [novela] and it was so comfortable for them, that they immediately dove in 
and identified with the characters in the story.  They were talking about the same 
trials and tribulations that the characters were experiencing, and how they had the 
same things in their lives…The comments were, “I can use this to talk to my family 
members about taking better care of our health, or to understand more about my 
diabetes.”  It was a piece that clearly had a lot of resonance, so I would say that you 
want to find those pieces. 
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Echoing the findings of the AHRQ’s Decreasing Disparities Strategy Workgroup of 
the Agency for Healthcare Research and Quality, several respondents stressed the 
importance of family and trust in the Hispanic culture:   
That’s what we really struggle with – with our [corporate culture] – it’s a very Anglo 
rational linear approach to health disparities and how we can address them.  It’s 
“Well, we’ll work with them on consumer-directed health and get them to take care of 
themselves.”  That won’t work.  It’s about doing it within the context of the family and 
the community, a very circular relationship. 
 
Also, it’s really important that the imagery is right.  Latinos are all about family, not 
about anything else.  So that’s what needs to be reflected… When we say family in 
the Latino culture, it is not mom, dad and 1.2 kids.  It’s really aunts, uncles, 
grandparents, nieces, nephews, friends, godparents, people that aren’t blood related 
but they’re still family.  It could be huge. 
 
A lot of folks want to serve the Latino market, but they start doing direct mail pieces, 
just like they would in the Anglo market, and it doesn’t work.  The Latino’s view of 
brand is very different than a non-Latino’s view of brand.  The brand has to be 
humanized, and that sounds really strange, but it’s really about building a 
relationship with the brand.  When a Latino makes a purchase, and we’re great 
consumers, but we make purchases based on, “Is that a nice person I’m buying 
from, and is that company a nice company?”  Price and quality become secondary to 
all of this.  It really is about that emotional connection with people. 
 
 
Finally, simply translating English to Spanish is risky, ineffective, and a potential 
waste of money.   
People need to make sure that they don’t just translate.  They need to transcreate.  
I’ll give you one quick example of how you can get into trouble translating.  You’ve 
seen those billboard ads that say, “Got milk?”  A literal translation of that [into 
Spanish] would be “Are you lactating?” 
 
What we found is that when we have offered...screening reminders in Spanish, the 
translation is technically accurate.  Grammatically it is correct, but it sounds very, 
very formal and stilted.  It sounds translated.  If you look at the English screening 
reminder script, it is very warm and friendly and personable.  In the translation 
process, all that is lost.   
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Key Finding 4:  In a testament to the costs and difficulties of creating strong 
evaluation designs, and the time interval required to measure sustained 
improvements for chronic diseases such as diabetes, most of the programs in 
operation are using process measures; in addition, the majority of plans are not yet 
ready to report results.   
This is a particularly relevant finding, given the fact that most of these organizations 
have been formally addressing racial and ethnic disparities for more than four years.  It 
speaks to the length of time necessary to develop and implement programs; to allow for 
measurable impacts to be made; to design evaluations methods; to collect, integrate, 
analyze and verify data for a complex, chronic condition such as diabetes. 
Table 8 provides a summary description of the interventions employed by the health 
plans with programs to reduce disparities in Hispanics with diabetes, along with the goal(s), 
type(s) of measure, and results for each program.  In the table, programs are grouped by 
intervention type employed (payer-member, payer-provider, payer-community, and multi-
factorial). 
Most plans are tracking and reporting against process measures; only one is tracking 
outcome measures.  While all eight programs have stated goals, five goals are process 
measures (improving HEDIS diabetes screening rates for Hispanic members, increasing 
Hispanic member enrollment in disease management programs, and identifying members 
for whom additional interventions may be appropriate and effective).  One plan’s stated goal, 
to reduce gaps in care, is neither reported nor tracked.  Only two programs have goals that 
are outcome measures; interestingly, they are associated with the same organization (one 
of the two integrated delivery systems included in the study).  
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Table 8.  Intervention Descriptions, Goals, Measure Type and Results for Programs 
Implemented by Participating Health Plans (by Intervention Type) 
Payer-Member Intervention Goal(s) Type of 
Measure 
Results 
Disease management program outreach 
to Hispanic members through telephone 
and mail  
Increase diabetes 
disease management 
enrollment among 
Hispanic members 
Process Not yet reported. 
Ethnic-tailored, interactive voice 
response telephone call offering 
members more information about the 
complications of diabetes 
Identify members for 
whom additional 
interventions (e.g., health 
coaching) may be 
successful 
Process Initial campaign of 
24,000 calls netted 
4,000+ positive 
responses.n  Second 
campaign planned for 
2009. 
Culturally tailored diabetes screening 
reminders via automated outbound 
telephone calls. 
Increase HEDIS diabetes 
screening rateso for 
Hispanic members 
Process Not yet reported. 
Culturally adapted diabetes screening 
reminders via automated outbound 
telephone calls. 
Increase HEDIS diabetes 
screening rates for 
Hispanic members 
Process No observed impact to 
date. 
Mail and automated outbound telephone 
screening reminders 
Increase HEDIS diabetes 
screening rates for 
Hispanic members 
Process Not yet reported. 
Payer-Provider Intervention Goal(s)  Outcome(s) 
Plan outreach to physician practices 
operating in heavily disparate zones to 
build awareness of the issue and to offer 
health plan assistancep 
Close care gaps Outcome Not tracked or reported 
Payer-Community  Goal(s)  Outcome(s) 
Using health behavior and health 
education resources, educate and assist 
Hispanic diabetics in disease and self-
management 
Improve diabetes self-
management 
Outcome 200 patients with notable 
reduction in HbA1c 
levels 
Multi-Factorial Goal(s)  Outcome(s) 
Payer-Provider:  Health plan provides 
physicians with a disease/patient 
registry to identify Hispanic diabetic 
members at risk for cardiovascular 
disease.   
 
Provide-Member 
Patients are prescribed a drug regimen 
to reduce morbidity and mortality risk 
 
Payer-Member:  Outreach program to 
educate Hispanic members in diabetes 
self-management and cardiovascular 
risk reduction program adherence 
Reduce cardiovascular 
mortality of Hispanic 
diabetic patients by 50% 
and save $300 per 
patient per year 
Outcome Not yet reported.  A 2006 
small cohort study found 
a 65% adherence rate.92 
 
 
                                               
n Numbers represent diabetic patients of all races/ethnicities who were called and responded. 
 
o HEDIS diabetes screening measures include eye examination, HbA1c test, LDL-C test, and nephropathy 
monitoring. 
 
p Target population includes, but is not limited to, Hispanics with diabetes. 
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Key Finding 5:  The sustainability of industry funding for health disparity reduction 
initiatives is questionable, given the pervasive absence of dedicated funding, the 
difficulties in producing a formal business case for health disparities, and the 
weakening economy.  This is particularly true for diabetes. 
None of the health plans included in this study have a specific line item budget for 
expenses (other than for full-time employees), either for health disparities reduction in 
general or for specific programs.  Each program or intervention is funded on a project-by-
project basis.  This suggests that funding will evaporate in the continued absence of a 
demonstrated return on investment for health disparities efforts.  It also indicates that 
organizations do not yet see addressing health disparities as an ongoing component of their 
health care operations, as they do for such functions as quality improvement and disease 
management.  
Only one of the health plans interviewed, a for-profit firm, has developed a formal 
business case for addressing health disparities to date.  Most organizations were either 
leveraging senior executive support and/or the visibility of their participation in highly visible 
external partnerships such as the NHPC.    As one respondent noted, though, executive 
support on its own can be a shaky foundation for health disparities efforts:  “We’re just trying 
to keep the [health disparities] initiative alive.  We lost our executive sponsor.” 
While most respondents felt the need to eventually establish a business case or ROI, 
there were varying degrees of urgency about producing one.   
We have a health equity and quality area whose purpose was created in September 
of this year [2008], and our tasks are to lead the corporate initiatives around health 
equity, health disparities and language access and health literacy.  That’s our 
business case.  We have a work plan.  We have goals.  We have measures.  We 
won’t be asked to demonstrate a return on investment. 
 
It’s too soon to tell [whether our health plan has a business case for addressing 
health disparities].  We’ll know more next year.  That’s a huge discussion point that 
many have had in terms of the ROI [return on investment] on this.  A lot of work has 
been done through the NHPC [National Health Plan Collaborative] about the 
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business case for reducing disparities.  I don’t think we have the answer quite yet.  I 
don’t think anyone has the answer. 
 
 
In this regard there was a difference between not-for-profit and for-profit firms.  
Those health plans that felt the most pressure and had expended the most energy and effort 
to establish a business case, regardless of their success to date, were the for-profit firms.  
For example, one for-profit health plan used race and ethnicity data for its employee 
population to create a business case for addressing health disparities.  (It lacked that data 
for its members at the time.)  The organization found that female Hispanic and African 
American employees were utilizing significantly fewer prenatal visits, experiencing 
significantly more maternal and fetal complications, and driving much higher labor, delivery 
and post-natal costs than its Asian American and Caucasian employees.  It found similar 
disparities between those groups in diabetes care and complications.  The organization was 
able to extrapolate the total costs of health disparities in those two conditions across their 
entire member population -- and subsequently develop a very compelling business case for 
addressing health disparities through medical expense reduction.q 
Finally, several respondents registered concern about the recent economic downturn 
and real and anticipated budget impacts on programs with -- as of yet -- no solid quantitative 
ROI.  (These interviews occurred before the four-figure layoffs announced by Blue Cross 
Blue Shield of Michigan, Wellpoint, Aetna and Cigna in January of 2009.)93 
What is being impacted is our funding for evaluations.  We had hoped to do focus 
group evaluations of our materials.  That has been cut…so I can say that there has 
been an impact. 
 
We lost our project team [as a result of workforce reductions]. 
 
 
 
                                               
q Respondent asked that specific figures on disparity differences and total cost savings not be disclosed. 
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Key Finding 6:  Despite the numerous obstacles to demonstrating the return on 
investment for reducing health disparities, plans have secured funding and support 
for health disparities reduction programs by starting small, demonstrating value 
relatively quickly, and then scaling.  In addition, many have developed both internal 
and external partnerships to pool resources and knowledge, to help create critical 
mass in the industry, and to build visibility and momentum for health disparity 
reduction efforts. 
Respondents stressed the importance of testing small interventions in targeted 
segments, as opposed to tackling entire populations.  This approach both minimizes 
programming costs and facilitates the design of robust and valid program evaluations.  
Focus on things that have a quicker ROI so that you can really show the benefit.  
Then once you get that, it’s like stepping-stones, you kind of build on your prior 
successes.  
 
Just take a little piece at a time.  If you do cultural competency of your work force, 
then you try to build on that to go out to your providers.  Then you look at health 
literacy, or you build in health literacy at the same time.  So you just, you have to 
have a working model out of which your key levers that you want to try to impact.  
For us, it’s the clinical disparities; it’s the continued collection of primary data and the 
use of that data; it’s cultural competencies, both work force and providers; it’s health 
literacy, it’s making sure our language access meets the needs of our membership; 
it’s on external community partners because we know we can’t do it alone; it’s on 
achieving an impact.   
 
Internal partnerships between such areas as quality improvement, marketing, the 
diversity office and others allowed health plans to pool their internal resources and to 
building groundswell from the multiple perspectives represented.  External collaboration, 
particularly high-visibility partnerships, exerted pressure on the organization to commit 
resources to programs and initiatives aimed at reducing racial and ethnic health disparities.  
Such partnerships also allowed health plans to share knowledge with other organizations 
and gain valuable knowledge and insights from the groups’ collective experiences. 
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Until this year, we never had a dedicated staff, and the only way we were able to 
achieve anything is through collaboration internally and externally…[we] had the 
opportunity to participate in a[n external partnership].  Because that was a high-
visibility initiative, [health plan] wanted to, once we had committed to participation, 
there was commitment to help us get the work done that was expected in the 
collaborative.  So that was a key external partnership, and we could also leverage 
what some of the other health plans were doing. 
 
As a part of the [external partnership], we all had to work on a disparities 
initiative…and we really wanted to make sure we were doing it right [because of the 
high visibility of the group]. 
 
 
Key Finding 7:  In a corollary to several earlier findings in the key informant 
interviews, several respondents indicated that reducing racial and ethnic disparities 
in diabetes is not the place for organizations to begin addressing disparities in a 
sustainable manner. 
As the necessity to establish a business case for addressing health disparities in 
general, already an imperative for for-profit firms, becomes even more critical during an 
economic recession, starting with diabetes may ultimately end up eroding organizational 
support for investments in disparity reduction efforts in general.  This is supported by 
Leatherman et al., who found that it took one health plan ten years to recognize a return on 
investment for its diabetes disease management program – and that such patience for 
conditions like diabetes is needed to fully amortize the start-up costs to avoid premature 
conclusions that such programs are not cost-effective.78  
While this may lead to an unfortunate short-term focus on conditions other than 
diabetes, the establishment of a larger and more firm evidence base for the cost-
effectiveness of racial and ethnic disparities reduction initiatives will likely stimulate an 
eventual focus on diabetes, given its toll on quality of life, its costliness, and its 
pervasiveness. 
I would recommend that they start [with something other than] diabetes.  Even 
though that’s the hot topic of the decade…I would recommend that they start with 
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prenatal care or asthma, just because the chance of having ROI will be that much 
higher and quicker.  Once they can demonstrate that, then they will be much more 
likely to secure funding for future programs. 
 
The challenge with, I think diabetes in particular, is that it is such a long-term chronic 
condition.  Extensive ROI like amputation, blindness or what not, there’s no way we 
can get that kind of results, ROI calculated within say a year-and-a-half to two years.  
Whereas if you were to implement other disease management programs or health 
coaching programs that are geared toward more episodic types of conditions, case 
in point would be prenatal care and visits, or asthma-related…But with diabetes, 
even people who are taking care of their diabetes really, really well may be just 
deferring their complication.  By many years, it’s true, but maybe eventually they 
would still have blindness or tissue damage and what not.  I don’t believe that a true 
medical cost ROI is a part of the evaluation for diabetes, but if we do find that the 
HEDIS screening measures really work well, then presumably long-term this would 
help reduce the medical costs. 
 
In a related finding, several respondents noted the criticality of appropriately 
managing the expectations of key stakeholders -- such as those in a position to approve or 
deny initial or additional funding -- about what can and cannot be accomplished, and when. 
You have to be in this for the long haul.  This is not a short-term win.  This is not a 
fly-by-night strategy.  If you want a quick hit, if you want quick cost savings, if you 
want to show something that’s going to achieve huge impact in a short period of 
time, working on healthcare disparities, especially diabetes, is not your topic. 
 
In a nutshell, for people who work in [reducing health disparities], I would caution 
them that there are times when you feel like you are not making progress, but you 
really are.  I think everything builds on each other. The important thing is to start 
small and take baby steps and get whatever wins you can.  If you can only do one or 
two custom pieces, do that, even if you don’t get a full-on program.  Eventually, it will 
build into a more robust program. 
 
 
Key Finding 8:  Integrated delivery systems, given their inherent advantages in 
collecting data, influencing provider behavior, and delivering coordinated care, may 
be the bellwether for successfully addressing health disparities.   
A number of studies have examined the importance of coordinating the often-
disparate components of primary care in the treatment of diabetes and other chronic 
illnesses, and have suggested that integrated delivery systems in the United States are 
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currently better positioned than contracted delivery systems to successfully treat such 
diseases.77, 94-96 Such systems have control over more aspects of the delivery process, 
including provider performance measures, salaries and incentives.  In addition, the relative 
uniformity of systems and processes between the health plans and providers in integrated 
delivery systems also makes investments in critical enabling technologies such as electronic 
medical records and disease/patient registries less risky and less complex.  Such tools can 
greatly facilitate the exchange of data and information, such as member race and ethnicity, 
care alerts, treatment algorithms, etc.  The organizational umbrella also promotes shared 
goals among a wider range of stakeholders. 
Those findings are supported by the two integrated delivery systems included in this 
study.  While one plan is not specifically addressing health disparities in Hispanics with 
diabetes, it is using electronic medical records in its hospitals and physician practices to 
collect member race, ethnicity, country of origin, and language preference data.  The health 
plan is also measuring its performance on a statewide metric for “optimal diabetes care,” a 
composite of five measures, three of which are outcome measures (HbA1c, LDL-C and 
blood pressure); the other two are aspirin and tobacco use.  In addition to providing 
translation services for more than 100 languages, the organization has implemented 
standard clinical improvements for its physicians (education and evidence-based 
guidelines).   
The other integrated delivery system included in the key informant portion of this 
study has implemented an outcomes-based, multi-factorial intervention (payer-member, 
provider-member, and provider-payer) approach to reduce the risk of cardiovascular disease 
in Hispanics with diabetes.  That same health plan has implemented a community-based 
program to improve glycemic control among Hispanics with diabetes, again measuring 
outcomes, and has seen a notable reduction in HbA1C levels among more than 200 
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patients.  It was, notably, the only health plan in the study to use either a multi-factorial 
approach or to be measuring outcomes in its program(s) to reduce health disparities in 
Hispanics with diabetes.  Finally, this health plan requires cultural competence training for all 
physicians, and it bases a portion of physician compensation on achieving benchmarks for 
eight medical indicators.    Both of these cases provide compelling examples of the relative 
advantage of integrated delivery systems over contracted delivery systems in data 
collection, provider performance, evaluation design and technology application. 
 
Key Finding 9:  Finally, recognizing the importance of enterprise involvement in the 
effort to address health disparities, most health plans are employing a cross-
functional committee approach -- often with dedicated leadership or support from one 
or more full-time employees – and are requiring cultural competence training for 
employees and providers.   
 In general, these cross-functional committees create goals and objectives for the 
organization’s health disparities reduction efforts, oversee activities, review the 
organization’s progress against the plan and goals, suggest new programs, and in some 
cases, review funding requests for programming.   They are typically composed of 
representatives from quality improvement, case management, informatics, marketing, 
customer service, the diversity office, human resources, and, in some cases, community 
relations. 
We have a multi-departmental committee that reviews and sort of sets the agenda 
throughout the enterprise on healthcare disparities, and that reports up to the 
highest levels of quality management at [health plan] on a regular basis. 
 
[Our CMO] pulled together a multidisciplinary group across the entire enterprise of 
[health plan] not only on the commercial side, but on the Medicaid side, as well, to 
talk about how we can really move our company forward, knowing we have 
enhanced and increased diversity in the population we cover…We met monthly over 
the past year to look at various aspects of a multicultural approach in the business, 
specifically in the clinical arena. 
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In a finding consistent with the observation that most plans see the reduction of 
health disparities as a quality improvement responsibility, half of the respondents indicated 
that the health care division leads their organization’s committee.  Those same 
organizations have dedicated from one to three full-time employees, employed by the health 
care division, to support or lead their health disparities reduction committee or task force; 
none of the other four plans interviewed have dedicated staff.   Each of these plans has a 
project manager, program manager, program director or medical director; two of those plans 
have one to two data analysts reporting to the program director or medical director.  For 
example, one health plan has created a specific functional area, staffed by three full-time 
employees, to lead corporate initiatives around health equity, health disparities, language 
access and health literacy.  This functional area leads a multi-departmental committee, 
which in turn sets the health disparities agenda for the enterprise; creates supporting goals 
and objectives; develops and manages the workplan to achieve those goals and objectives; 
and reports the results of quarterly progress reviews and the annual program evaluations to 
the organization’s senior executive team.r 
From a cultural competence training standpoint, most of the participating health 
plans require it for all clinical personnel with member contact, at a minimum; half provide it to 
their physicians. 
For us, one of our key levers [to impact health disparities] is cultural competency 
training, for both our work force and our providers. 
 
We’ve embarked on cultural competency training for our employees for the last two 
years.  We’ve done homegrown training.  We done lunch and learns.  We’ve done 
formalized training through Quality Interactions, e-based learning tools.  We’ve had 
probably close to 2,000 employees trained via Quality Interactions. 
                                               
r Respondent preferred not to disclose the organization’s specific goals and objectives for disparities reduction. 
  
CHAPTER 6:  DISCUSSION 
 
In order to address its central question of whether there is a role for private payers in 
reducing the incidence of type 2 diabetes among Hispanics in the United States, this study 
examined two key sets of questions:   
 
1. What are health insurers and other organizations doing to help provide more 
effective care to groups (such as Hispanics) that may experience barriers to care as 
a function of gaps in health care operations and the clinical encounter?  What 
measurable outcomes are being created as a result of such steps? 
 
2. What, if anything, is being done by health insurers and other organizations to 
specifically address the health disparities experienced by Hispanics?  In diabetes 
incidence among Hispanics?  In the incidence of any health condition(s) among 
Hispanics?  What evidence of reduced incidence currently exists? 
 
The document review and key informant interviews were designed to provide insights 
into both sets of questions, with differing areas of focus.  The objectives of the document 
review were to provide an industry-level overview of activities aimed at reducing or 
eliminating racial and ethnic health disparities; illuminate any measurable outcomes of such 
efforts; and to determine target organizations for the key informant interviews.   The goal of 
the key informant interviews, in turn, was to develop a more detailed understanding of the 
objectives, drivers, structure, effectiveness, level of organizational commitment, and lessons 
learned from the development and implementation of program aimed at reducing the 
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incidence of diabetes among Hispanics – and to tap into any information not readily 
available through public access means.  The findings of both study components – the 
document review and the key informant interviews -- are summarized along that analytical 
framework in this chapter. 
 
 
What are health insurers and other organizations doing to help provide more effective 
care to groups (such as Hispanics) that may experience barriers to care as a function 
of gaps in health care operations and the clinical encounter? What measurable 
outcomes are being created as a result of such steps? 
 
Concern about the impacts of health disparities continues to grow among health 
care system stakeholders, as does the number of health plans and other organizations 
taking visible and public action.  This is due in large part to a dawning recognition that, as 
racial and ethnic minorities make up an increasingly larger segment of the U.S. population, 
addressing disparities is crucial to making further improvements in the quality of health care 
and health outcomes.  The document review found evidence of action being taken to reduce 
health disparities (particularly for Hispanics and Hispanics with diabetes) by dozens of 
health insurers and other organizations.  That total includes the nine member plans of the 
National Health Plan Collaborative; the eleven participants in the Improving Health Care 
Quality for Racially and Ethnically Diverse Populations workgroup; the AHRQ’s Decreasing 
Disparities Strategy Workgroup; members of the Blue Cross and Blue Shield Association 
Healthcare Disparities Workgroup; and many others.  
These groups, along with other health plans and agencies, have embarked on pilot 
projects and case studies to examine the efficacy of various intervention methods at 
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reducing racial and ethnic health disparities; examined the multitude of challenges 
surrounding the collection of member race, ethnicity and language preference data; and 
begun to tackle the barriers to producing a business case for addressing disparities.  
Through a series of publications of case studies, lessons learned and toolkits, these groups 
have sought to share their knowledge, results and experiences with other organizations 
seeking to join the fight against health disparities.   They are also seeking to influence 
relevant policy issues, such as the development and enforcement of guidelines and 
standards for measuring health disparities and for categorizing races, ethnicities and 
languages. 
The most visible effort, and the one most relevant to this study, is that of the NHPC.  
The nine member health plans have focused primarily on data collection and examination of 
diabetes-related performance data for disparities, implementing pilot interventions to reduce 
health disparities, collecting health plan members’ primary race, ethnicity and language 
preference data, improving language access, and determining the business case and ROI 
for the reduction of health disparities.40    
The Improving Health Care Quality for Racially and Ethnically Diverse Populations 
Workgroup, a component of the CHCS’ Best Clinical and Administrative Practices initiative, 
developed new ways to identify members of racial and ethnic subgroups, to measure the 
gaps in care that these groups experience, and to explore ways to improve health care 
quality.  The workgroup developed methods to uncover and address disparities in three 
targeted areas, including diabetes, and published three case studies describing intervention 
approaches to improve diabetes care, two of which addressed Hispanic populations.38 
The Decreasing Disparities Strategy Workgroup of the Agency for Healthcare 
Research and Quality (AHRQ) embarked on a learning network project to reduce the 
diabetes disparity in the Hispanic population. The workgroup targeted community health 
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centers with a predominately Hispanic population for this intervention, which was conducted 
from June 2006 to January 2007. The project demonstrated that clinics can make significant 
progress in their patient goal-setting performance, even when patients participate in short 
learning sessions over an abbreviated period of time.  The workgroup also produced lists of 
lessons learned at both the clinic and patient levels.84 
Outside of these national collaboration efforts, many health insurance plans are 
individually and actively addressing health disparities through a variety of mechanisms. For 
example, Blue Cross Blue Shield of Florida has several disparities-related initiatives, 
including the collection of race and ethnicity data directly from members (on a voluntary 
basis), bilingual (Spanish and English-speaking) case managers, a multilingual contact 
center and a series of Spanish language online tools.50  In addition, in 2005, Blue Cross and 
Blue Shield of Massachusetts awarded $3 million in grant funds to reduce racial and ethnic 
health care disparities.54 Highmark (also a member of the NHPC), has formed a multi-
dimensional approach to focus on health care disparities, and has been addressing this 
issue for more than five years.  The reduction of racial and ethnic health disparities is now a 
corporate goal for Highmark.53  Finally, CareFirst, the Blue Cross and Blue Shield health 
plan covering northern Virginia, the District of Columbia and Maryland, is addressing health 
disparities among specific racial and ethnic groups through a variety of initiatives under their 
CareFirst Commitment program.55-58 
In addition, organizations such as the Robert Wood Johnson Foundation and the 
Bureau of Primary Health Care are working with clinics and other community-level partners 
to reduce health disparities. Examples of this include the Advancing Diabetes Self-
Management project at La Clinica De La Raza in Oakland, the Diabetes Health Disparities 
Collaborative, the Campesinos Sin Fronteras initiative, and the Open Door Health Center’s 
Prescription for Health Diabetes Project.81, 82, 84, 97    
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According to the materials published by these organizations, these individual and 
collective efforts have resulted in measurable and largely positive outcomes (refer to Table 
5).  NHPC member health plans, through their Phase One diabetes-related pilot 
interventions, saw such results as:  significantly increased HbA1c and LDL-C screening 
rates for previously non-adherent members, as well as improvements in those members’ 
glycemic control; increased eye exam rates for Hispanic members with diabetes; success in 
getting diabetics in high disparity physician practices to visit their doctor for screenings; 
improved quality measures with respect to diabetes; and increases in diabetic members’  
disease management self-confidence (and a coincident decrease in their program level of 
care requirements).     
The Improving Health Care Quality for Racially and Ethnically Diverse Populations 
Workgroup published several examples of successful interventions to reduce health 
disparities: an increase in the number of minority women entering prenatal care during their 
first trimester and improved birth outcomes; a significant increase in HEDIS rates for the 
appropriate use of asthma controller medication among a target population of African 
Americans and Hispanics) a significant increase in HbA1c testing rates, eye exam rates, 
LDL-C screening rates, and nephropathy monitoring rates among target populations of 
Hispanics with diabetes. 
Community-based efforts such as the Open Door Health Center’s Prescription for 
Health Diabetes Project and the Diabetes Health Disparities Collaborative have resulted in 
both improved diabetes self-management and processes of care for Hispanics.82, 97 
In addition to producing outcomes-based results such as these, these individual 
actors and collaborative groups, along with researchers, foundations and agencies, are 
raising awareness of the issue across government, health care and public sectors.  These 
players are accomplishing this heightened awareness through visible advocacy for the 
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reduction of racial and ethnic health disparities, and the publication and promotion of the 
results and analysis of pilot projects, case studies, and lessons learned.    As a result, 
healthcare system stakeholders are deepening their understanding and knowledge of the 
issue, and there is emerging coalescence along several key themes. 
One uniform conclusion reached by both health plans and other health care system 
stakeholders is that collecting race and ethnicity data on health plan membership is 
foundational to determining the impacts of health disparities and potential actions to address 
them; unfortunately, the majority of hospitals, health plans and physician practices do not 
routinely capture this data.   As discussed earlier, a wide range of local, regional and 
national multi-stakeholder collaborative efforts are working to reduce disparities in 
healthcare, but efforts are still hampered by race and ethnicity data challenges – namely, its 
collection, quality, reliability and usability.  As a result, considerable variability in methods for 
collecting race and ethnicity continue to exist, severely limiting the health system’s ability to 
generate comparable information on health status and quality for all racial and ethnic 
groups.   To help overcome these barriers, the NQF and NHPC, among others, are calling 
for the development of national guidelines for the collection and use of primary data in 
health care quality improvement, along with disparities-sensitive measures that can be used 
for public reporting, performance measurement and disparities improvement. 
These steps will also be critical if provider pay-for-performance programs are to be 
leveraged in the fight to eliminate racial and ethnic health disparities.  These programs 
currently lack the necessary characteristics to reduce disparities, and health plans, in order 
to address these shortages, must collect race and ethnicity data, emphasize conditions of 
higher prevalence in minorities to providers, reward improvement for reducing health 
disparities, and encourage nationally prominent organizations to establish disparity 
guidelines or measures. 
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Quality improvement programs are the logical starting point for health plans to 
reduce or eliminate health disparities in diabetes for Hispanics, but there is growing 
consensus they must be broadened and extended to incorporate multi-factorial and 
culturally tailored approaches. Dozens of reports and studies point to the efficacy of multi-
factorial and culturally tailored approaches in reducing care gaps, and several have found 
evidence indicating that these methods specifically improve diabetes health outcomes and 
potentially reduce health disparities among Latinos.   For diabetes in particular, some of the 
most powerful and successful interventions are multi-factorial, targeting patient, provider, 
organization, and community factors simultaneously.   This finding supports the notion that 
collective action and partnerships among and between health plans, providers, communities 
and agencies are a critical component of reducing racial and ethnic gaps in care.    
Cultural tailoring for Hispanics includes the use of bicultural community health 
workers, peer support, and family inclusion, as well as the integration of cultural components 
specific to the Hispanic population.   Such cultural components include, for example, the 
importance of food, family and trust; the variances in language and cultural norms among 
the different Latino subpopulations, based on their countries of origin; the concept of 
physicians as authority figures in the Latino culture (and its impact on patient participation in 
self-care); and the low literacy levels among many Hispanic populations, among others. The 
success of culturally tailored quality improvements may be a result of their ability to provide 
a mechanism of individualizing care for ethnic minorities.  
Finally, questions about what types of interventions are most valuable and most 
important for Hispanics with diabetes (as well as for other races/ethnicities and disease 
conditions) continue to plague both researchers and health care system stakeholders, as do 
the complexities and costs of designing effective evaluation techniques to measure the 
return on investment for these programs.  In addition, the lack of long-term evidence of 
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outcomes success, particularly for diabetes interventions, continues to concern 
stakeholders.  Most studies have only examined improvements over a 1-2 year period; 
however, diabetes is a long-term chronic disease and has a complex set of drivers and 
symptoms, making it difficult to definitively measure the efficacy and sustainability of 
interventions.  These issues present a multitude of challenges to creating a solid business 
case and clear roadmap for addressing health disparities, which may make the allocation of 
scarce health plan resources to such programs even more difficult to achieve.    
Despite these potential barriers, there is a clear call from many observers to move 
beyond documentation to action.  A growing number of stakeholders and participants in the 
debate over what to do, how to do it, how much it will cost and how much value it will 
provide are beginning to assert that it is time for the health disparities dialogue to give way 
to concerted action. 
 
 
 
What, if anything, is being done by health insurers to specifically address the health 
disparities experienced by Hispanics?  In the incidence of diabetes among 
Hispanics?  What evidence of reduced incidence currently exists? 
 
As outlined above, a number of health plans, agencies, foundations and other 
players are taking visible and public action against racial and ethnic health disparities.  As 
the document review revealed, many of these efforts are focused on Hispanics, due to their 
explosive growth as a segment of the nation’s population, and the acknowledgement that 
this group, in particular, faces both cultural and linguistic barriers to care.  While that portion 
of the analysis focused on and provided an overview of industry-level activities and 
outcomes, the key informant interviews were designed to provide deeper insights into any 
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health plan efforts designed to reduce the incidence of diabetes among their Hispanic 
members.   
The eight health plans represented in the key informant interviews are strongly 
committed to reducing racial and ethnic health disparities.  Most have been addressing the 
issue for several years, and thus represent the leading edge of health plan activities and 
efforts to reduce or eliminate racial and ethnic gaps in care.  None of them are addressing 
the reduction of the incidence of diabetes in Hispanics, nor have they produced any 
evidence that incidence has been reduced. 
All of the health plans included in the study have recognized the importance of 
collecting members’ race and ethnicity data, and have allocated scarce organizational 
resources over a period of several years to that effort.  The plans are using direct means 
(such as HRAs, member surveys, and enrollments forms), indirect methods (such as geo-
coding and surname analysis), or a combination of the two approaches to collect the data.   
Most of the health plans included in this study are using cross-functional committees 
to coordinate their organization’s efforts to address disparities.  The majority of these 
programs is led by a member of the health care division, usually a medical director, program 
director or program manager from the quality improvement area. Committees are typically 
composed of representatives from quality improvement, case management, informatics, 
marketing, customer service, the diversity office, human resources, and, in some cases, 
community relations. 
While many plans have dedicated full-time employees to the support and leadership 
of their disparity reduction efforts, and most are participating in external partnerships, none 
of the health plans have gone so far as to develop a specific line item budget for health 
disparity programming.  Programs are treated and funded as specific projects.  This may 
undermine any potential for synergies between programs and ultimately, the overall 
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effectiveness of individual projects or programs and the organization’s portfolio of disparity 
reduction initiatives as a whole.  That factor, combined with the seeming lack of integration 
with each health plans’ foundation initiatives (typically targeted at the community level), may 
explain the relative absence of multi-factorial approaches in the study group. 
Only one plan has produced a quantitative business care for addressing racial and 
ethnic health disparities, using the organization’s own employee data.  In this instance, the 
health plan discovered significant disparities between racial groups in prenatal and diabetes 
care, and in maternal, delivery and diabetes complications and claims costs, simultaneously 
proving the existence of racial and ethnic health disparities in the plan’s member population 
and providing evidence of the potential medical cost savings of eliminating such gaps in 
care. 
Primary drivers for these health plans to originally initiate actions to reduce racial and 
ethnic health disparities include the recognition that care gaps are widening; that overall 
population health improvement cannot be achieved without addressing these gaps; and that 
quality improvement programs are not currently positioned to effectively address health 
disparities.   The 2003 IOM report, Unequal Treatment:  Confronting Racial and Ethnic 
Disparities in Health Care, provided a compelling impetus for half of the organizations 
included in the study, as did the notion that addressing health disparities is “the right thing to 
do.”  Other drivers common to the group included a strong push by senior management, 
anecdotal data from physicians, activity by the health plan’s competitors to address health 
disparities, and growing demand from national accounts for evidence that the health plan is 
actively seeking to reduce health disparities. 
The health plans included in this study see strong ties between building 
organizational cultural competence and reducing health disparities, although the vast 
majority of current cultural competence training efforts are aimed at only a segment of plans’ 
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employee populations – usually clinical personnel with customer contact (such as case 
managers and health coaches).  This is not surprising, given that six of the eight plans 
participating in the study use contracted network arrangements.  In one of the first 
differences between organizations at the categorical level noted in this study, the mandating 
of cultural competence training as a condition of employment for providers exclusively by the 
two integrated delivery systems reinforces the notion that these delivery systems may be 
better positioned to influence physician behavior, at least in the short term. 
In a finding consistent with the document review, programs specifically targeted at 
Hispanics with diabetes are still nascent in the study group, most having been in existence 
from less than one year to two years.  None of the eight health plans represented in this 
study are addressing the reduction of incidence.  Instead, most plans are leveraging current 
quality improvement programs and methods, and are thus primarily focused on payer-
member interventions (as opposed to payer-provider, provider-member, or multi-factorial 
interventions).  Payer-member interventions most often include diabetes screening 
reminders delivered via mail and telephone. Only one plan is employing a community 
intervention, despite the preponderance of reports, studies and briefings extolling the 
effectiveness of such methods.   (This finding excludes any community-level foundation 
efforts, which do not seem to be integrated with the organizations’ mainstream disparities 
reduction efforts.) 
None of the programs included member or provider incentives that were specific to 
the program itself.   In another finding consistent with the document review, none of the 
plans include the specific reduction of health disparities as a component of their provider 
pay-for-performance program, citing a lack of race and ethnicity data and an accepted 
disparity measure.   Two health plans have overall, composite health indices that are used 
as components of the organizations’ employee incentive compensation and provider 
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compensation, respectively.  While these incentives are not directly aimed at reducing racial 
and ethnic health disparities, there is likely an indirect effect, given that the rising health 
improvement tide must float all boats – regardless of race or ethnicity -- in order for the 
health plan to meet its goals. 
While each of the eight programs aimed at reducing health disparities in Hispanics 
with diabetes has a stated goal – seven of which are measurable -- most program goals are 
process measures (such as improving HbA1c and LDL-C screening rates), as opposed to 
outcome measures.  Only one of the programs tracking process measures has reported or 
observed any results to date – in this case, the number of members reached via outbound 
IVR calls that requested additional information about diabetes.  In another observed 
difference between integrated delivery systems and contracted delivery systems, one of the 
two integrated delivery systems included in this study has two programs in place to address 
health disparities in Hispanics with diabetes – both of which are the only programs in the 
study group that include outcome measures. 
Key informants supplied a fairly robust (and surprisingly uniform) set of lessons 
learned. Each respondent stressed the criticality of establishing of the existence of health 
disparities within the health plan’s member population.  Half noted the importance of 
developing a deep understanding the specific characteristics and needs of the Hispanic 
population(s) that the plan serves or is seeking to serve -- and acquiring resources with the 
appropriate skills and experience to meet those needs.    An equal number of respondents 
cautioned health plans to avoid making the erroneous assumptions that all Hispanics are the 
same, and that Hispanics will respond to the same messages and methods as non-Hispanic 
populations.     
Several participants exhorted other plans to do something – to start small, to 
demonstrate value relatively quickly, and then to scale up their efforts.  Two respondents 
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specifically mentioned that diabetes may not the right place to start building a business case 
for addressing health disparities, given the length of time required to demonstrate true cost 
savings.   Other lessons included securing senior executive buy-in for organizational support 
and visibility; engaging in internal and external partnerships to add momentum and 
resources to the effort and to leverage knowledge from and synergies with others; and to be 
patient – tackling health disparities is a long-term initiative. 
Finally, any discussion of this topic would be incomplete without addressing the new 
(Obama) administration and the potential impacts of health care reform on racial and ethnic 
health disparities.  President Obama has been clear and consistent about the need for 
health care reform, and has promised to take definitive action by the end of 2009.  At the 
time of this writing (March 2009), no legislation had been passed, but a white paper entitled 
Call to Action:  Health Reform 2009 had been published by Senate Finance Committee 
Chairman Max Baucus (D-Montana) in November of 2008, and a stimulus bill positioned as 
a “downpayment on health care reform” had been recently proposed by President Obama. 
The reduction of disparities is not called out as a specific goal by the administration, 
in the stimulus package, or in the white paper -- and is unlikely to be, given the current state 
of the economy.  Nor are any of the federal policy levers that Lurie et al. suggest are needed 
specifically addressed.  (These include requiring the collection of racial and ethnic identifiers 
for patient populations; setting standards for the usage and collection of such standards; 
and ensuring that culturally diverse populations receive appropriate health care through the 
enforcement and dissemination of CLAS standards and best practices.)44  However, there 
are key elements of both the stimulus package and Senator Baucus’ plan that can 
potentially aid in the reduction of disparities.   
The first is improved affordability and access to coverage (such as individual 
mandates, employer “pay to play” requirements, guaranteed issue, restrictions on premium 
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rate adjustments for health status, and subsidies for small employers and individuals).  Such 
provisions can help reduce access-related drivers of disparities.  There is also an increased 
focus on, and funding for, prevention and wellness to fight preventable diseases and 
conditions with evidence-based strategies.  Type 2 diabetes is certainly a preventable 
disease, and support for evidence-based strategies may increase the focus on care that 
results in demonstrably improved outcomes. 
In addition, the stimulus package provides for funding for the Agency for Healthcare 
Research and Quality (AHRQ), the National Institutes of Health (NIH), and the Health and 
Human Services (HHS) Office of the Secretary to evaluate the relative effectiveness of 
different health care services and treatment options may lead to the provision of more 
individualized care – which a growing body of research indicates is effective in improving 
quality of care and outcomes, particularly for racial and ethnic minorities. 
Both the Baucus plan and the stimulus package call for investments and incentives 
(through Medicare and Medicaid) to ensure widespread adoption and use of interoperable 
health information technology, which can serve to jump-start efforts to increase the use of 
useful technologies such as electronic medical records and electronic prescribing in 
physicians' offices, hospitals and other medical facilities.  Such technologies can help with 
the direct collection of race and ethnicity data (as is the experience of the integrated health 
delivery systems examined in this study), and with medication adherence, for example.   
Electronic medical records can also help reduce linguistic barriers in the clinical encounter, 
as the information that they provide to physicians will reduce the reliance on the patient to 
understand and communicate his or her health history and status to care providers.s 
Another provision of the stimulus bill includes a potential expansion of the security 
and privacy elements of the Health Insurance Portability and Accountability Act (HIPAA).  
                                               
s From an interview with Harry L. Reynolds, Chairman of the National Committee on Vital and Health Statistics, 
March 24, 2009. 
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While a detailed discussion of that is beyond the scope of this project, one potential impact 
to efforts to reduce health disparities is that it may restrict or deny access to such critical 
data elements as race/ethnicity indicators for entities like health insurers and other payers. 
It is certainly too early to predict what will happen with current efforts at health care 
reform and the resultant impacts on racial and ethnic health disparities.  However, there is a 
renewed focus at the federal level to address many of the problems with our current health 
care system that affect all Americans -- affordability, access, cost, and demonstrable quality 
and effectiveness of care.  In many instances, our nation’s racial and ethnic minorities feel 
those gaps more acutely than those who do not experience the additional barriers to care 
that those cultural and linguistic differences present.  While a direct focus on reducing racial 
and ethnic disparities may not be in our nation’s immediate future from a federal policy 
standpoint, many elements of proposed health care reform may provide an indirect benefit. 
  
CHAPTER 7:  Conclusions 
 
 
There is a role for private payers to play in reducing the incidence of type 2 diabetes 
among Hispanics in the United States.  However, given the barriers to reducing or 
eliminating racial and ethnic health disparities in general that health plans currently face, 
successfully filling that role is a long-term proposition – one that must be preceded by much 
foundational work by all stakeholders in the health care system.   In the meantime, there is a 
more critical and immediate role that all private payers should play, if they have not begun to 
do so already – and that is to join the fight to reduce racial and ethnic disparities in health 
and health care.  Broader industry action will raise the level of the quality of care delivered to 
racial and ethnic minorities in general; improve the overall health of those populations; 
create additional momentum for necessary federal policy changes; enhance industry 
knowledge and expertise in addressing health disparities; increase the evidence base for 
program outcomes; and reduce the time it will take to solve this serious problem. 
Currently, more than thirty health plans in the United States are engaged in visible 
and public efforts to reduce racial and ethnic health disparities, both as individual plans and 
as part of collaborative arrangements with other health plans, agencies and foundations.  
Many of those efforts are focused on Hispanic and African American populations, given their 
relative size and the known cultural and linguistic barriers that their members face in the 
health care system.  A number of programs aimed at reducing gaps in care between 
population groups are focused on diabetes, given its prevalence, the billions of dollars that it 
costs the health care system each year, and its toll on the quality of life for those who suffer 
from the disease. 
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The activities and programs to reduce racial and ethnic health disparities in diabetes, 
however, are primarily focused on managing the disease and improving care for it, 
consistent with traditional health plan disease management approaches.  No programs are 
currently focused on reducing the incidence of diabetes among Hispanics.  Health plans are 
struggling to overcome the lack of accurate, comprehensive and reliable race, ethnicity and 
language preference data for their members, a costly and complex problem to solve.  That 
issue, combined with the absence of both federal guidelines for the collection and disclosure 
of race and ethnicity data in health care quality improvement and disparity guidelines or 
measures, leaves health plans severely hampered in their efforts to move beyond their 
current state.  Without such data, health plans cannot identify differences in health status 
and utilization across racial and ethnic groups, nor can they develop, implement and monitor 
intervention programs aimed at reducing and eliminating gaps in care.  Such data is also 
needed to help health plans set priorities, design programs, better understand the health 
needs of specific populations, evaluate performance differences among and within plans, 
geographic areas, physician groups, etc., and provide the foundation for rewarding good 
performance.   
As result, many health plans that are moving forward to address racial and ethnic 
health disparities most commonly employ member interventions (such as screening 
reminders) and process measures (such as HEDIS screening rates for diabetes).  Notable 
exceptions are the integrated delivery systems, which have control over more aspects of the 
delivery process, including provider performance measures, salaries and incentives.  The 
relative uniformity of systems and processes between the health plans and providers also 
makes investments in helpful technologies such as electronic medical records and 
disease/patient registries less risky and less complex.  Such tools can greatly facilitate the 
exchange of data and information, such as member race and ethnicity, care alerts, 
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treatment algorithms, etc.  The organizational umbrella also promotes shared goals among 
a wider range of stakeholders, and may explain the higher frequency of multi-factorial 
interventions in integrated delivery systems. 
Despite these challenges, there are a few success stories resulting from the efforts 
of health plans, agencies and foundations to reduce racial and ethnic health disparities, 
particularly in diabetes.  Outcomes range from increased adherence rates for screening and 
treatment protocols to improved glycemic control.  Due to the nascence of many of the 
programs focused on diabetes, and the length of time required to produce valid and 
meaningful outcome results for a complex and chronic disease like diabetes, no programs 
as of yet have reported solid outcomes, such as reduced morbidity, mortality or medical 
expenses. 
In conjunction with health plan efforts, researchers continue to seek evidence of the 
efficacy of different intervention types and approaches in eliminating or reducing gaps in 
care between racial and ethnic groups.  Their findings indicate that quality improvement 
programs, extended and broadened to include multi-factorial and culturally tailored 
approaches, show great promise as weapons in the fight to reduce racial and ethnic health 
disparities, particularly for Hispanics with diabetes.  In addition, a number of case studies 
and projects aimed at improving care for Hispanics have produced helpful lessons and 
guidelines on how to successfully integrate cultural components specific to the Hispanic 
population into quality improvement programs to enhance their effectiveness.  At the same 
time, health plans are increasingly realizing the criticality and value of understanding and 
meeting the specific needs of their minority populations, and are conducting focus groups 
and other research to better test intervention methods, messages and delivery vehicles to 
improve their effectiveness. 
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Finally, questions persist about the business case for reducing health disparities in 
diabetes care and outcomes for Hispanics – and there are no clear answers yet.  Health 
plans need more clarity about what types of interventions are most valuable and most 
important for Hispanics with diabetes, and what the return on investment is for these 
interventions.  Without more experience, better data on both member race and ethnicity and 
the costs and benefits of interventions, it is not yet possible to produce a solid business case 
for reducing racial and ethnic disparities in diabetes among Hispanics.   
However, thanks to the efforts of the National Health Plan Collaborative, The Center 
for Health Care Strategies, the Agency for Healthcare Research and Quality, individual 
health plans, health researchers, and the support of community-level initiatives by 
organizations like the Robert Wood Johnson Foundation, there is mounting – and promising 
– evidence that interventions aimed at reducing or eliminating gaps in care between 
Hispanics with diabetes and other groups are beginning to chip away at the problem. 
What is certain is that successful resolution of the overall problem of racial and 
ethnic health disparities, regardless of the target population or the target disease, will 
require the involvement of and action by all health care system stakeholders – payers, 
providers, members, communities, the government, agencies, and foundations.  Health 
plans are in a unique position to influence the majority of these players, through advocacy, 
strategies, interventions, incentives, partnerships, policies, and programs.  The more 
organizations that join the effort and take informed, targeted action, the sooner the problem 
of health disparities will recede into our nation’s past.   As Nicole Lurie put it, “Health 
disparities – less talk, more action.” 
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Limitations of This Research 
Limitations to this study include both those that are general to document review and 
key informant interview methods, as well as several that are specific to this study.  For the 
key informant interviews, the relatively small sample size, the sampling methodology and 
participation introduced selection bias.  This limitation was partially addressed through 
purposeful inclusion of at least two organizations in each of the sampling categories 
described in this study’s methods section (Chapter 3).  The categories included geographic 
coverage, organization type and delivery system type. 
General limitations of the key informant interviews include the fact that this 
component of the study relied heavily on the knowledge and expertise of the key informants 
interviewed.  Limitations were also introduced by the lack of availability of documentation or 
information in some instances on specific interventions, programs, and results.  Several 
respondents either refused to provide specific facts at certain points in the interviews, or 
asked that such information not be disclosed in the study. These details are considered 
confidential or proprietary trade secrets, and are therefore cannot be made publicly 
accessible, but their absence does leave data gaps in the study. 
The non-participation of seven of the fifteen health plans reduced the amount of data 
collected.  This factor undoubtedly narrowed the breadth and depth of observations 
produced by this study.  Given the almost equal distribution of the geography and 
organization type categorical variables between the participating and non-participating 
groups, it is unlikely that any significant bias was introduced in these areas.  In addition, the 
inclusion of both integrated delivery systems allowed for more robust comparison of the two 
types of delivery systems included in the study.  A review of the publicly available 
information on the interventions employed by the non-participating plans revealed no 
discernible patterns between the two groups (participating and non-participating) that would 
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indicate a common reason for refusal that would bias these results.  Instead, it appears that 
non-participation was generally based more on an individual representative’s time available 
to be interviewed, and his or her competing priorities, willingness or interest in participating.  
(The exception to this conclusion is the one health plan that cited legal reasons for its 
refusal to participate.) 
Key informants undoubtedly – and in most cases, unintentionally – injected bias into 
their responses, either due to presence of the researcher or to the respondents’ role in the 
program being evaluated.  A specific limitation to this study is the researcher’s dual role as a 
student and as a health plan employee, which was fully disclosed to all participants in the 
initial invitation.  This factor introduced both selection and response bias – for example, at 
least one organization declined to participate in the key informant interviews for this reason.  
It was apparent on a few occasions during interviews that this fact made it difficult or 
uncomfortable for subjects to respond to certain questions or probes for information.  
There was also a natural and expected variability in the respondents’ abilities to 
perceive the full extent and intention of the question(s), and to effectively communicate all of 
the information requested by the researcher.  Finally, for the key informant interviews, there 
was likely a tendency to underemphasize or omit information regarding failed programs or 
interventions, although the researcher found no evidence that this was the case. 
For the document review, several sources with inherent bias were used.  Examples 
include press releases and reports published by the same party or parties that participated 
in or sponsored the event, program or initiative.  For such reports, it was not always clear 
whether or by whom the information had been edited or reviewed.  In those cases, any 
outcomes or results were clearly stated to have been self-reported, allowing the reader to 
draw his or her own conclusions as to their validity (based on the information and the 
source).    In addition, there were limitations in the document review introduced by the 
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information quality.  For example, some documents may have contained inaccurate or 
incomplete information.   In a limitation similar to that of the key informant interviews, there 
may also be under-reporting of failed programs or initiatives, or those that produced no 
interesting or relevant results. 
 Unless otherwise stated, study limitations were addressed primarily through 
validation techniques.  For example, information from the key informant interviews was 
triangulated with publicly available sources of information.  In several cases, key informants 
were asked to affirm or clarify their responses, both during the interview and in subsequent 
correspondence. 
  
CHAPTER 8:  A PLAN FOR CHANGE 
 
 
 
The findings of this study – both of the document review and the experiences of the 
health plans interviewed -- suggest that the execution of a health plan’s role in reducing 
racial and ethnic health disparities will entail a multi-phased, incremental process.  These 
findings also suggest that, in order to quickly and effectively establish a business case for 
reducing disparities – a critical step in acquiring funding, resources and ongoing 
organizational support -- health plans should not start with diabetes.    
As outlined earlier, expanding the number of payer organizations engaged in 
addressing racial and ethnic health disparities will provide multiple benefits; it will improve 
both the quality of care delivered to racial and ethnic minorities in general and the health of 
those populations, create additional momentum for federal policy changes, enhance industry 
knowledge and expertise in health disparities, increase the evidence base for program 
outcomes, and reduce the time it will take to solve this serious problem.   
The purpose of this plan for change, then, is to help increase the number of health 
plans actively addressing racial and ethnic health disparities by providing them with a series 
of beginning steps.  In other words, its purpose is to help move the industry beyond dialogue 
to action, heeding the exhortations of several observers and participants in this study.  
An individual health plan’s starting point in tackling the problem of racial and ethnic 
health disparities will depend on a variety of factors.  These factors include the 
demographics and specific needs of its member population; the availability of member race 
and ethnicity data; organizational priorities; and the availability of the human and capital 
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resources necessary to undertake a program or programs to reduce racial and ethnic health 
disparities. 
 
Promising Practices 
Regardless of the specific target population or disease/condition chosen, the 
following steps are presented as a set of promising practices to guide organizations wishing 
to begin to address racial and ethnic health disparities though their first project or initiative.  
They are based on this study’s literature review, document review, and key informant 
interviews, 
 
Step 1:  Form an internal workgroup.   
The goals of the workgroup should be to:  educate themselves and the organization 
on racial and ethnic health disparities in general; stay abreast of emerging issues and trends 
in health disparities; create a preliminary business case for organizational action against 
health disparities; recruit an executive sponsor to promote the visibility of the issue; 
coordinate and oversee organizational efforts to reduce disparities; set goals for such 
efforts; monitor and report on progress against those goals; and seek and develop the 
necessary external partnerships that serve to further the organization’s disparity reduction 
goals. 
Accordingly, the workgroup should include key stakeholders that do or should have 
a role in organizational efforts to reduce racial and ethnic health disparities. The list of 
participants will be specific to each organization, but considerations should include areas 
that have responsibility for functions such as quality improvement, informatics, marketing, 
community relations, professional and institutional networks, diversity, human resources, 
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and customer service.  In addition, the health plan’s community foundation, if one exists, 
should be included in the workgroup.  
Members of the workgroup should leverage the wealth of information, tools and 
other resources published by: 
 The National Health Plan Collaborative (www.nationalhealthplancollaborative.org)  
 The Agency for Health Care Quality and Research (www.ahrq.gov)  
 The Center for Health Care Strategies’ Racial and Ethnic Heath Disparities issue area 
(http://www.chcs.org/info-url_nocat5108/info-url_nocat_list.htm?attrib_id=16310), which 
provides links to a number of studies and toolkits to reduce racial and ethnic health 
disparities 
 The Center for Health Care Strategies’ Best Clinical and Administrative Practices 
resource center at: 
http://www.chcs.org/info-url_nocat5108/info-url_nocat_list.htm?attrib_id=16518 
 The Robert Wood Johnson Foundation Quality/Equality program area 
(http://www.rwjf.org/qualityequality/)  
 
Using this information, the workgroup can develop a proposal and preliminary 
business case to establish awareness of the issue of racial and ethnic health disparities 
within the health plan population and to recruit an executive sponsor.  Excellent resources 
for building a business case, including journal articles, case studies, calculators, data sets, 
templates and other technical assistance can be found on the Center for Health Care 
Strategies’ website at http://www.chcs.org/info-url_nocat5108/info-
url_nocat_list.htm?attrib_id=15791. 
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Step 2:  Recruit an executive sponsor.  
The best individual for this role will vary by the size, structure and politics of the 
organization.  In selecting the sponsor, members of the workgroup should seek to strike an 
optimal balance between the individual’s formal role, visibility and status in the organization, 
his or her passion for and interest in the issue, and the political capital that he or she will 
bring to bear.  Likely candidates for consideration include the Chief Medical Officer and 
Chief Executive Officer.  Most of the health plans included in this study had recruited their 
organization’s Chief Medical Officer, as their programs are primarily extensions of their 
quality improvement programs.  To the extent that this effort may align with the enterprise’s 
overall strategy, the C-level officer who has responsibility for strategic development and 
execution should be considered. 
 
Step 3:  Develop an ongoing communications plan. 
 Identify all impacted internal and external stakeholders, such as health plan 
employees, key executives, members, providers, employer groups and the community at 
large.  Determine the relevant messages, media and timing for each group.  For example, 
specific recommended messages regarding the collection and use of member race/ethnicity 
and language preference data are addressed in Step 4 below.  In addition, as noted earlier, 
employer groups are showing growing levels of interest in what health plans are doing to 
address health disparities, as evidenced by the increase in the number of requests for 
proposal (RFPs) that include questions related to this topic (as cited by several plans 
participating in the key informant interviews). 
 
Step 4:  Choose a target population for evaluation of the presence of health 
disparities, and determine the race and ethnicity of that population. 
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There are various methods and approaches to accomplish this step, as highlighted 
by the experiences of the health plans participating in the key informant interviews and the 
members of the National Health Plan Collaborative.  If an organization collects EEOC data 
on employees, it may be able to leverage that data for analysis.  If that is not an option, 
there are several organizations that specialize in imputing race and ethnicity data, using 
techniques such as geo-coding and first name and surname analysis.   More information on 
this topic can be found on the Robert Wood Johnson Foundation website at 
http://www.rwjf.org/qualityequality/product.jsp?id=34022 or at the RAND Corporation 
website (www.rand.org) by performing a search using the term “geo-coding.” 
In addition to being critical to the reduction or elimination of health disparities and the 
overall improvement of care quality, the collection and use of member race, ethnicity and 
language preference data can provide important marketing and customer service benefits to 
health plans.  Such data can help health plans determine the presence and size of various 
racial and ethnic groups in their overall population, providing important insights into potential 
product offerings and targeted marketing and education campaigns for certain groups.   It 
can also help health plans make informed decisions about the necessity and type of 
culturally and linguistically appropriate customer service. 
 Several sources stress the importance of addressing enrollee, employee and 
provider concerns about the collection and use of member race and ethnicity data.41, 98, 99  
When asked to provide such information, members must be told that it will be used to 
improve the quality of care for its members.  They must also be given assurances that the 
information will not be used to determine coverage, claims payment (or to discriminate in 
any way), and that it is both voluntary and confidential. 
 Health plan employees and provider group staff are critical both in the collection and 
successful use of member race/ethnicity and language preference data to reduce health 
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disparities, and thus must fully support it.  Key messages to these stakeholders include that 
access to such information can help them provide better care to members by strengthening 
the member-provider and member-payer relationship and communications; improve cross-
cultural education and skills; increase member compliance and adherence to treatment and 
medication; reduce the potential for misdiagnosis or non-diagnosis of medical conditions 
due to language barriers; identify the need for interpreter and translation services; and 
increase the representation of racial and ethnic minorities in health professions.41, 100 
 Finally, employer groups can be important partners in the collection of member 
race/ethnicity and language preference data, as they often collect it for purposes such as for 
the EEOC.  However, employers often have concerns over the legality of sharing employee 
data; health plans need to develop and communicate messages to dispel those inaccurate 
perceptions and to assure employers of the intended uses of the data.41, 101 
 
Step 5:  Establish that disparities exist in the member population. 
Using conditions like prenatal care, asthma, and diabetes, develop disparities 
indices for each disease and population.  In general, a health disparities index (HDI) 
measures each health plan’s progress toward eliminating disparities by comparing the 
difference between each racial and ethnic subgroup’s rate on specific measures and the 
best-performing subgroup’s rate for the same measure. The quality component of the index 
measures each subgroup’s performance against an external norm, such as HEDIS 
measures. The index can be used for needs assessment, to identify overall patterns of 
disparities at the plan level, to evaluate ongoing disease management programs, and to 
determine whether racial and ethnic disparities are increasing or decreasing.38   An example 
of a disparities index for HbA1c test rates for persons with diabetes is shown in Figure 7; a 
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step-by-step approach to targeting improvements in diabetic care, using a health disparities 
index, is outlined in Table 9. 
 
Figure 7.  Disparity in Annual HbA1c Testing Rates for Persons with Diabetes38 
 
 
 
Table 9:  Analytic Steps to Target Improvements in Diabetic Care for Hispanics48 
Step 1:   Select the population of Hispanic beneficiaries and a white reference group. 
Step 2:   From those pools, select beneficiaries with diabetes. 
Step 3:   Determine if beneficiaries have recommended diabetic care. 
Step 4:   Select geographic areas. 
Step 5:   Assign beneficiaries to geographic areas, such as counties. 
Step 6:   Create a disparities index (calculated as the percentage of Hispanic beneficiaries 
receiving the recommended care divided by the percentage of whites receiving 
the recommended care). 
Step 7:   Identify areas with large numbers of Hispanic diabetic beneficiaries and a large 
disparities index. 
Step 8:   Design and implement culturally sensitive, evidence-based intervention programs. 
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Step 6:  Stratify and prioritize disparity reduction opportunities. 
Based on the results of the index, determine which population(s) and disease(s) or 
condition(s) have the largest gaps in care.  If possible, determine or extrapolate the direct 
costs of those gaps in care to your organization.   The ROI resources on the CHCS website 
(http://www.chcs.org/info-url_nocat5108/info-url_nocat_list.htm?attrib_id=16310) will be 
helpful in this step.  
 
Step 7:  Pick a population and a condition, and determine program objectives. 
The population and condition chosen should allow for a fairly rapid establishment of 
the value of the intervention(s) and a platform on which the health plan can build a business 
case.  A key consideration is the feasibility of designing and executing a valid evaluation 
instrument.  Conditions with shorter intervals from intervention to measurement, such as 
prenatal care and asthma, are promising candidates.  Plan to test small interventions at first. 
 
Step 8: Acquire the right resources to help plan, develop, execute and maintain the 
program. 
Determine the specific needs of, barriers to care faced by, and the most effective 
potential interventions methods for the target population.  This can be accomplished by 
drawing on existing research and by conducting investigations (such as focus groups, in-
depth interviews, and needs assessments).  In doing so, acquire and utilize resources that 
are skilled, knowledgeable and experienced in the culture(s) and language(s) of the 
population in question.     
An important component of this step is the determination and pursuit of the 
granularity of data required to design effective interventions.  Data may include, for example, 
such elements as country of origin, language isolation, socioeconomic status, and 
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geography.  This is particularly critical to ensure the adequate and appropriate integration 
and leveraging of cultural components specific to the target population.   
 
Step 9:  Design the program. 
Based on the research conducted in Step 6, design the intervention(s) to meet the 
specific needs of the target population.  Important additional design considerations include 
intervention types (member, provider, community and multi-factorial interventions, as well as 
program evaluation mechanisms.  Finally, identify and pursue the internal and external 
partnerships that will necessary in carrying out the program.    
 
Step 10:  Based on the program objective(s) established in Step 5, determine the 
specific program metrics and design the program evaluation.   
Most health plans already have program evaluation teams and resources, as these 
are typically applied to monitor and measure the effectiveness of disease management, 
utilization management, quality improvement and other health-related programs.   The types 
of inputs that will likely be required for program evaluation are claims data, financial data on 
programming costs, and process and outcome measures (such as HEDIS and CAHPS).  
Key design principles for program evaluation are simplicity and measurability. 
For background on program evaluation, The Centers for Disease Control and 
Prevention’s Framework for Program Evaluation in Public Health, produced and reviewed by 
hundreds of public health professionals, provides a summary of evaluation terms and 
concepts, as well as a step-by-step model for program evaluation.  It can be found at 
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4811a1.htm. 
 
Step 11:  Implement the program. 
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Step 12:  Continuously evaluate program performance, make the necessary 
adjustments, and discuss and document lessons learned.  
Apply the program evaluation developed in Step 8.  One potential outcome of the 
program evaluation is that the program is discontinued for nonperformance reasons.  
Several key informants indicated that their health plan had been forced to make such a 
decision on at least one occasion; both pointed out that, as difficult as these decisions may 
be, they are necessary to both build trust in the disparities reduction effort and to preserve 
funding for future programming. 
 
 
Additional Considerations 
This list consists of other steps or practices for health plans to consider adopting that 
are not specifically related to a particular program or intervention, or are longer term in 
nature.  These are also derived from the literature review, the document review, and key 
informant interviews. 
 
Build internal awareness of racial and ethnic health disparities through health 
disparities and cultural competence training and education for employees (at a 
minimum) and providers (ideally). 
Several of the organizations taking part in this study are using online cultural 
competence training tools such as Quality Interactions (http://www.qualityinteractions.org/) 
for their employees and providers.  Quality Interactions is interactive and role-based, 
meaning that the scenarios presented vary by the participant’s role.  Others are using less 
costly static online content, which can often be developed in-house, to educate health plan 
employees about health disparities in general and to provide cultural competence training. 
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Consider how and when to begin the direct collection of member race, ethnicity, 
country of origin, and language preference data. 
This is a time- and labor-intensive process, but it does produce high data accuracy 
rates.  Such accuracy is necessary to: definitively evaluate and measure the impacts of 
disparities and efforts to reduce them; to set performance measures; and to hold 
participants accountable to those measures.  This is a multi-year effort that can involve 
information systems, forms and process changes.  One key consideration is the number of 
systems of record for members that the health plan uses; the more systems involved, the 
more costly and complex this will be to implement and maintain. 
Direct data collection sources include the member enrollment process, disease 
management programs, health risk assessments (HRAs), clinical encounters, direct 
outreach to members, member web portals, member surveys, and member-initiated contact. 
Other health plans currently engaged in member race and ethnicity data collection 
have found that combined methods (indirect and direct data collection) are required to 
obtain complete and accurate information.  This is due to the aforementioned barriers 
presented by the lack of consistent standards and rules for data collection and the disparate 
information technology systems used by the various stakeholders collecting and using this 
data.  The NHPC toolkit provides a wealth of information on the various methods for data 
collection and their inherent advantages and disadvantages.  The toolkit can be downloaded 
from the Robert Wood Johnson Foundation site at: 
http://www.rwjf.org/qualityequality/product.jsp?id=33960. 
 
Create or join existing external partnerships with other stakeholders to share 
knowledge and best practices, and to create critical mass for policy changes. 

 
 
 
 115 
Most of the key informants interviewed for this study pointed to the value of external 
partnerships, primarily the collaborative efforts developed by the CHCS and the Blue Cross 
and Blue Shield Association.  As outlined earlier, the primary benefits of such partnerships 
(and thus health plan motivations to participate in them) center on sharing knowledge and 
lessons learned.  Such partnerships are also serving to achieve greater industry alignment 
and mass to reduce racial and ethnic health disparities in general.  In addition, groups like 
the NHPC are working together to advocate for the establishment of federal standards and 
guidelines for race and ethnicity data disclosure and collection, and health disparities 
guidelines or measures.  
 
Include member health improvement as part of corporate goals and employee 
incentive compensation programs.   
The indicators that underlie member health improvement can and should be tailored 
to the health plan’s specific member population and its needs, and those indicators may or 
may not explicitly address the reduction of racial and ethnic health disparities.  However, 
such a step accomplishes two things:  it establishes a visible commitment on the part of the 
health plan to improving the health of its members; and, if designed, monitored and 
executed properly, it will put positive pressure on the health plan to reduce gaps in care for 
all members, regardless of the source of those gaps (race/ethnicity, socioeconomic status, 
health literacy, etc.). 
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APPENDIX A 
Key Informant Interview Guide 
 
Introduction 
Thank you for agreeing to participate in this study.  As you may know, Hispanics in 
the United States suffer from diabetes more than any other racial or ethnic group, and at 
twice the rate that white Americans do – a problem often referred to as a “health disparity” 
between Hispanics and other groups.  The results of this study will be used to develop a 
deeper understanding of the mechanisms – both current and potential -- that health insurers 
and other organizations are using or may use to help address this problem. 
The information collected in this study will be kept confidential.  Your specific 
answers will not be attributed to you or your organization.  It will be used in summary form to 
discuss the structure and effectiveness of diabetes intervention programs, and to form 
specific recommendations for organizations wishing to take action against this problem. 
Your participation in this study is purely voluntary, and there are no consequences if 
you refuse to participate, or if you decide to discontinue the interview (which you may do at 
any time).   Do you have any questions about the research or the interview?  
I’d like to ask you a few questions about how your organization is addressing health 
disparities in the Hispanic community. 
 
1. What was the original impetus for development of your program(s)?  (Examples may 
include such things as service area demographics, claims experience, community 
awareness, corporate vision/mission, requests for community support through such 
mechanisms as charitable foundations, etc.) 
2. Are there stated goals or objectives for the program(s)?  If so, what are they? 
3. What percentage of your customer base is Hispanic?   

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4. Do you capture race/ethnicity data on your members?  If so, how is it used? 
5. When (month and year) did you implement your program? 
6. What functional area is accountable for development, implementation and evaluation 
of the program (e.g, Health Care, Operations, Marketing, etc.)? 
7. In general, how does the program work?    
8. Where are the points of intervention?   
9. What are the incentives for stakeholders to participate in the program?  To comply 
with it? 
10. What metrics, if any, have you established to measure its effectiveness?   [Probe:  
Process measures (such as eye exams, foot exams), clinical outcome measures 
(such as HbA1C test results), functional outcome measures (SF-12 or other health 
status measures), cost avoidance measures (reduced hospitalizations), or other 
measures (increased productivity, presenteeism, etc.).] 
11. What results or outcomes have you experienced to date?   If there are no 
measurable outcomes to date, what early evidence do you have about the success 
of the program? 
12. Do you have continual budget commitment?  For how long? 
13. How much has your organization spent to date to develop and implement your 
program? 
14. Is there anything else that you think other organizations tackling this issue should 
know, either before they begin, during implementation, or while the program is in 
effect? 
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